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ABSTRACT
As in vitro fertilization (IVF) becomes more acceptable for the treatment of human
infertility, it is essential for clinics to have in place an optimal embryo culture system.
The objective of this study was to evaluate whether freezing and storing human embryo
culture medium will alter embryo post-thaw viability. In consecutive experiments,
commercial culture medium was frozen at -20°C and at -80°C and stored at 4°C until its
use in IVF. Each IVF-derived replicate of bovine embryos contained a laboratory control
group, a fresh commercial culture medium group(s) and a frozen-thawed commercial
culture medium group(s). The commercial culture medium was supplemented with 15%
of BSA for days 1 through 4 of in vitro culture and on day 4 was supplemented with 9%
of glucose. Embryos were cultured to day 8 of the experiment and then embryo
development was evaluated and morphology was evaluated using the RED Score
system. In Experiment 1, zygotes (n=2,094) were in vitro cultured in medium that had
been frozen (-20°C) with storage times ranging from 3 days to 10 weeks. It was found
that embryo culture medium frozen at -20°C and stored for up to 10 weeks did not cause
a decrease in 8- to 16-cell embryo or blastocyst development for those embryos cultured
in medium frozen for 3 days to 6 weeks over the fresh medium (0 weeks). In Experiment
2, zygotes (n=3,727) were in vitro cultured in both fresh and frozen commercial culture
medium (-80°C) that was stored for 0, 1 or 2 weeks before use. This study indicated
embryo culture medium frozen at -80°C stored for up to 2 weeks did not cause a
decrease in 8- to 16-cell embryo or blastocyst development over that of the fresh
medium (0 week). In summary, it was concluded that there was no difference in the
blastocyst development rate or morphology at the end of the culture period in medium
frozen at -20°C for up to 10 weeks or in medium frozen at -80°C for up to 2 weeks.

xi

CHAPTER I
INTRODUCTION
In the second half of the 20th century, there was development and advancement
in controlled culture techniques for early stage mammalian embryos leading to the first in
vitro fertilization (IVF) offspring of several species, including humans. Due to the
development of improved in vitro culture conditions, murine offspring were reported from
the transfer of in vitro cultured embryos (McLaren and Biggers, 1958). Whitten (1957)
previously reported success in developing 8-cell mouse embryos to the blastocyst stage
in vitro using a defined culture medium. In 1959, first time mammalian offspring (a
rabbit) was reported from the transfer of in vitro fertilized embryos (Chang, 1959).
Decades prior to Whitten’s accomplishments, Albert Brachet was first to report
keeping a rabbit blastocyst alive and developing for 48 hours outside the mother’s body
in blood plasma (Brachet, 1912, 1913). Lewis and Gregory (1929) were able to film the
development of rabbit eggs under the microscope on glass slides from the initial
cleavage stages to the blastocyst stage (see Alexandre, 2001). Prior to this time, the
basic culture medium used to incubate embryos was either blood plasma or serum.
In an effort to address the metabolic requirements of mouse embryos, Whitten
(1957) and Brinster (1963) improved culture conditions to the extent that culturing from
the 2-cell stage to the morula stage became relatively easy, while also being efficient and
reproducible. Even with the early success of mouse embryo culture, Alexandre (2001)
reports that scientists thought it was unimaginable to develop valid experimental
strategies for culturing mammalian embryos without a serum- or a plasma-free medium,
since the composition of these body fluids was complex and highly variable.
In 1978, the first human baby was produced by in vitro fertilization by biologist
Robert G. Edwards and gynecologist Patrick Steptoe (Steptoe and Edwards, 1978). It
was not until four years later that Bracket et al. (1982) reported the first ruminant
offspring (a bull calf) from in vitro fertilization. Subsequently, the first IVF-derived
offspring were reported in the two other domestic ruminants, goats (Hanada, 1985) and
sheep (Cheng et al., 1986).
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Today’s quest has led to finding a more defined culture medium, without the
variability of the components used by the early researchers such as Brachet and Lewis.
Once a desired medium is decided upon there are quality control tests that must be
performed. Most fertility clinics set up an animal model system to evaluate culture
media, as well as perform a number of assays to test for various factors. A number of
authors (Purdy, 1982; Trounson, 1982; Vijayakumar et al., 1987; Naaktgeboren, 1987;
Davidson et al., 1988a, 1988b; McDowell et al., 1988) have suggested validation from
the performance of an assay for mammalian embryo culture to control the suitability of a
preparation of culture medium before using it for human IVF. For stronger results and
less variation a number of in vitro replicates must be provided within the same culture
medium.
Recommendations and regulations have been set regarding the storage time
period for embryo culture media. The current procedures are to manufacture a new
batch of media every 2 weeks (Purdy, 1982; Quinn et al., 1984; Gerrity et al., 1992;
McLendon, 1992). Adhering to these guidelines creates a limited number of IVF
replicates performed using a single batch of culture medium, reducing the data available
for comparison. Replication among one single batch is important because gametes and
embryos are being exposed to the same treatments. Due to variation between batches
of culture media or variation between commercial culture media production laboratories,
the use of one single batch of medium can assess embryonic development in vitro more
clearly.
Extended refrigerator storage at 4°C or frozen storage of embryo culture media
has been suggested to overcome this limited storage time barrier. Unfortunately, only a
few investigators (Naz et al., 1986; Bernart et al., 1990; De Silva, 1993; Bell et al., 1995)
have evaluated the effect of refrigerated or frozen stored culture media on embryo
development and the frozen-thawed viability of components in embryo culture media.
The quality of the culture medium has been reported to be a crucial factor
influencing the success of IVF in human infertility programs (Jones et al., 1982; Purdy,
1982; Trounson, 1982; Dandekar and Quigley, 1984; Quinn et al., 1984; McDowell et al.,
1988). Therefore, the advantages of using the extended storage time created by
refrigerator-stored or frozen-stored embryo culture media can be very beneficial. The
number of assays, as well as IVF cycles performed, within one batch of medium can be
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greatly increased. This would create a better understanding of the potential in vitro
culture (IVC) ability of a particular medium.
With an increase in the number of human assisted reproductive treatment (ART)
cycles performed in the United States almost doubling from 64,681 cycles in 1996 to
122,872 in 2003 (Centers for Disease Control and Prevention 2003 Assisted
Reproductive Technology Success Rate Report), it is also important for commercial
culture media companies to be able to efficiently produce a mass amount of media to
keep up with the demand. This review will evaluate IVF-derived blastocyst production
using fresh and frozen-thawed human commercial culture medium to culture bovine
embryos.
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CHAPTER II
LITERATURE REVIEW
In Vitro Fertilization of Mammalian Embryos
The process of mammalian in vitro fertilization (IVF) is the joining together of a
male and female gamete outside of the body. For fertilization to occur the medium
conditions must be optimal. There are a number of events that must take place before
an embryo develops, resulting in implantation.
Oocyte Maturation
For fertilization to occur an acrosome reacted spermatozoan (sperm) enters a
matured oocyte. During oocyte maturation there is progression of nuclear maturation
from the germinal vesicle of the arrested dictyate stage, through meiosis I to metaphase
II and extrusion of the first polar body (First and Parish, 1987). There are a few key
factors that are important for complete oocyte maturation to occur. Moor and Gandolfi
(1987) indicated that especially important are the development of proteins in the
cytoplasm which regulate: meiotic events, sperm decondensation, formation of the male
pronuclear envelope, initiation of cleavage, completion of cleavage-stage embryo
development and the ability to produce a viable offspring.
All of these regulatory events can be affected by the duration of the in vivo or in
vitro maturation time of the oocyte and the culture conditions during in vitro maturation.
Common defects resulting from fertilization of immature oocytes include failure of male
pronuclear development (Thibault et al., 1975; Thibault, 1977) and failure to progress to
organized blastocyst stage embryos (Staigmiller and Moor, 1984; Leibfried-Rutledge et
al., 1987).
Sperm Capacitation
Sperm must also go through a maturation process known as capacitation before
the male gamete is able to fertilize an oocyte (Austin, 1951; Chang, 1951). This process
normally takes place in the female reproductive tract. However, in the in vitro
environment a culture condition must be recreated similar to that of the environment in
vivo. Capacitation consists of two main functions, an initial sperm membrane alteration
(Yanagimachi, 1981; Wolf et al., 1981; O’Rand, 1982; Ahuja, 1984; Langlais and
Roberts, 1985), which allows the sperm to undergo the second phase, the acrosome

4

reaction (Yanagimachi and Usui, 1974). In mammalian species, sperm must begin to
penetrate the cumulus and corona radiata with an intact acrosome. There is a release of
enzymes from the acrosome of the sperm, such as hyaluronidase, starting the digestion
of proteins in the zona pellucida enabling fertilization. The acrosome reaction of the
sperm is then stimulated by the interaction of the contact between the sperm and the
zona pellucida. Fusion of the plasma membrane occurs with the outer acrosomal
membrane vesiculation thus, exposing the acrosome contents.
Oocyte Activation and Fertilization
In mammalian species, once the first sperm binds to the zona pellucida activation
of that oocyte occurs. To prohibit polyspermy, penetration of the zona by more than one
sperm, the oocyte responds with a cortical reaction. This cortical reaction produces a
block to polyspermic fertilization. There is a massive exocytosis of cortical granules
containing a mixture of enzymes released into the perivitelline space, which causes the
zona pellucida to harden. Also the sperm receptors are lost preventing additional sperm
from binding to the zona pellucida.
Once the individual sperm penetrates the zona pellucida, the sperm nucleus
decondenses in the cytoplasm of the oocyte, resulting in the swelling of the sperm head
forming the male pronucleus. Completion of meiosis II allows the formation of the female
pronucleus to become complete and pronuclear fusion or syngamy occurs. Fertilization
has occurred forming a zygote and then with mitosis the first cleavage of the new embryo
(2-cell).
Completion of all of these steps is fundamental to successful in vitro fertilization.
In addition, it should also be pointed out that sperm concentration, time of sperm-oocyte
interaction, medium quality and temperature are all important in successful fertilization
and for developmentally competent zygotes (First and Parrish, 1987).
The production of viable embryos from in vitro fertilization (IVF) is dependent on
the availability of a suitable in vitro culture system capable of supporting developing
embryos to the morula or blastocyst stage for transplantation. With optimal culture
conditions the embryo undergoes compaction of the blastomeres followed by
differentiation of the inner cell mass (ICM) and blastocoele development. The embryo
genome becomes activated early in a process known as the maternal to embryo
transition, which occurs at a different cell stage in various species. In this transition, cell
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regulation is transferred from the maternal RNA to the embryo for continued
development.
Human In Vitro Fertilization (IVF)
In 1978, Steptoe and Edwards were first to successfully produce a human baby
by in vitro fertilization (Steptoe and Edwards, 1978). Since the early 1980s, many of the
applied human embryo culture protocols and resulting implantation rates remained
relatively unchanged for decades.
Behr and Wang (2004) reported that for the past two decades the majority of
human embryos conceived through IVF have been transferred between day 1 and 3
post-insemination at either the pronucleate stage or the cleavage stage. The reason for
transferring this stage embryo stems primarily from the inability of the embryo culture
systems to support the development of viable blastocysts at acceptable rates. However,
reports from a number of investigators, such as; Barnes et al. (1995), Gardner et al.
(1998), Jones and Trounson (1999), Cruz et al. (1999), Behr et al. (1999), Schoolcraft et
al. (1999), Milki et al. (2000), Gardner et al. (2000) and Alper et al. (2001) have reported
increased blastocyst formation and pregnancy results using in vitro culture to the
blastocyst stage. Newer culture systems are now more consistent and more day-5 and
day-6 blastocysts are available for transfer in women.
There are advantages of culturing embryos to the blastocyst stage, which include
being able to select viable embryos for transfer and improving the synchrony of the
uterus with embryo development. However, there are also disadvantages of culturing
embryos to the blastocyst stage. Extended time in culture is thought to create
detrimental effects on human embryos that may, in part, be responsible for the
increasing risk of monozygotic twinning (Behr et al., 2000; Menezo and Sakkas, 2002) or
possibly a propensity to skew the sex ratio by transferring blastocysts (Menezo et al.,
1999). Therefore, a decision must be made on what stage is better to transfer the
human embryo. Less time in culture will result in a lower possibility of selecting the
highest quality embryo. However, an extended time in culture to the blastocyst stage
may cause genetic abnormalities in the embryos (Behr and Wang, 2004).
In the studies reported by Gardner et al. (1998), Cruz et al. (1999), Schoolcraft et
al. (1999) and Milki et al. (2000), it has been confirmed that higher implantation rates can
be achieved by the transfer of human embryos at the blastocyst stage. It should be
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noted that acceptable implantation rates can be achieved with cleavage stage embryos.
However, with improved implantation rates with transferred blastocysts, the question of
which stage embryo to transfer arises. Alper et al. (2001) indicated contradicting views
by citing that a number of reports to date have employed blastocyst transfer in good
prognosis patients only (Gardner et al., 1998; Schoolcraft et al., 1999) and although
pregnancy rate and implantation rate were very impressive, an excellent success rate
with the transfer of cleavage embryos would be expected in this selected group of
patients as well.
Extended culture of the embryo usually results in one or two blastocysts of the
group with the highest developmental potential at the time of transfer. Furthermore,
transfer of a blastocyst stage embryo into the uterus allows for better synchronization of
the embryo with the uterus. In the study by Gardner et al. (2000) these assumptions are
supported by pregnancy rates of 87% obtained using sequential media in patients who
had a good response to gonadotropin stimulation. Comparable results have yet to be
equaled with day-3 transfers. Earlier, Cruz et al. (1999) demonstrated blastocyst transfer
being effective even for patients with multiple IVF cycle failures. Coskun et al. (2000)
and Plachot et al. (2000) have also reported comparable implantation rates for day-3 and
for day-5 embryo transfers.
A concerning problem with human Assisted Reproductive Technology (ART)
programs is the potential for an increased risk of multiple pregnancies. With the
increasing accomplishments of fertility programs there is an increasing demand for high
success pregnancy rates among patients. To enhance the chances for a pregnancy,
more than one developing embryo is usually transferred into the patient (in the United
States not in Europe). The problem with transferring more than one embryo is that
multiple implantations occur and these types of pregnancies create greater risk factors to
the mother and the IVF offspring. Bergh et al. (1999) indicated concerns regarding the
risk of the consequences that multiple pregnancies pose on the mother and children. In
a previous study, Martin and Welch (1998) found that women undergoing IVF treatment
face a 20-fold increased risk of twins and 400-fold increased risk of higher order
pregnancies. Therefore, researchers are faced with the challenge of identifying the best
approach to embryo culture and transfer that would result in a pregnancy, but with a
minimal chance of a multiple pregnancy. Blastocyst culture appears to be a possible
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solution to this problem by limiting the number of embryos transferred into the uterus. Hu
et al. (1998) reported that in women who were aged <35, transferring either four poor
grade, two fair grade or two good embryos resulted in 35% pregnancy rates with no high
order multiple gestation. However, Alper et al. (2001) indicated that when more than two
blastocysts are transferred, high order multiple gestations are more likely to happen and
the benefits of the technique are lost. Milki et al. (2000) compared transferring 2.4
blastocysts with 4.3 cleavage stage embryos and found a higher pregnancy rate with
blastocyst transfer (68% versus 46%) but also a higher triplet rate (12% versus 4%).
Extended culture could possibly have a negative effect on in vitro development
and implantation potential where culture conditions are suboptimal. In vitro culture has
been reported to affect gene expression and embryo metabolism in animal model
systems such as; sheep (Young et al., 2001), bovine (Behr and Wang, 2004) and mice
(Doherty et al., 2000), especially with extended culture. Rienzi et al. (2002), Utsunomiya
et al. (2002) and Levron et al. (2002) have confirmed these findings. Rienzi et al. (2002)
and Utsunomiya et al. (2002) have found no difference between day-3 embryo transfers
and day-5 embryo transfers, whereas Levron et al. (2002) showed lower pregnancy rates
for day-5 compared with day-3 embryo transfers. It should not be overlooked that effects
of extended culture on human embryos may, in part, be responsible for the increased
risk of monozygotic twinning (Behr et al., 2000) and increased proportion of male
offspring after blastocyst transfer (Menezo et al., 1999).
Furthermore, Leese et al. (1998) reported that embryo culture conditions are
known to affect several parameters including the kinetics of development, cell allocation
to the inner cell mass and trophectoderm, embryo metabolism and genomic expression.
Nagy et al. (1993), Moore and Reik (1996), Dean et al. (1998) and Young et al. (2001) all
reported studies showing the effects that culture conditions can have on the expression
of imprinted genes on such animals as sheep and mice. The effect of culture conditions
on human imprinted genes is still unknown. Young et al. (2001) reported the decreased
expression of the IGF2 and imprinting gene H19 on fetuses derived from blastocyst
transfer after IVF in sheep. Dean et al. (1998) and Young et al. (2001) proposed that
fetal abnormalities found as a consequence of culture during embryo development could,
in large part, be due to the change in status of imprinted genes. Beechey (2000) and
Khosla et al. (2001) further supported this idea by stating that several imprinted genes
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are known to play key roles in murine fetal growth and development. Behr and Wang
(2004) have suggested that embryo culture to the blastocyst stage before embryo
transfer in sheep and cattle can result in a higher incidence of fetal and perinatal loss.
Young et al. (2001) have proposed that fetal abnormalities can be attributed to embryo
culture conditions, and in sheep may be linked to reduced expression of the imprinted
Igf2r gene. Doherty et al. (2000) found that H19 expression was affected by different
blastocyst culture media using a mouse model. These findings suggested that culture
conditions do indeed have an effect on imprinting genes that can be altered by the
embryo culture medium.
At this stage it is unknown whether the culture conditions used in human ART
programs do affect the expression of human imprinted genes. However, Behr and Wang
(2004) have proposed that differences do exist between in vivo-derived and in vitroderived embryos, possibly attributed to culture induced stress. Kovacic et al. (2002)
indicated because of the contradictory outcomes of extended culture, certain doubts still
remain about human blastocyst transfer. A number of questions arise when transferring
embryos at this stage such as, whether the culture media totally satisfies the nutritional
needs of embryos, whether more blastocysts would develop in vivo rather than in vitro,
whether prolonged culture has any effect on the developmental potential of the embryo,
and whether 5 day cultivation is suitable and justifiable in all cases, even in cycles with a
low number of oocytes (Kovacic et al., 2002).
Trounson (1982) reported that in human in vitro fertilization systems the first
cleavage should occur between 22 and 30 hours after insemination and thereafter at 10to 12-hour intervals. He noted that fragmentation and uneven cleavage is indicative of
abnormal development or suboptimal culture conditions. The same clinic documented
that all of their pregnancies developed from embryos with normal cleavage states,
although some had small cytoplasmic fragments in association with equal sized
blastomeres. However, Rijnders and Jansen (1998) pointed out that morphology may
not be a good predictor of human blastocyst formation because 50% of the good quality
day-3 embryos will become blastocysts but so will 20% of the poor quality embryos.
Alper et al. (2001) stated since the uterus is a better environment than current blastocyst
culture media, we should be cautious in assuming that failure to reach the blastocyst
stage indicates that the embryo never had implantation potential. They also noted that
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between 2% and 40% of patients will have to cancel their transfers because none of their
embryos will develop to day 5 of culture.
Behr and Wang (2004) described the conservative approach their clinic used in
switching to the introduction of blastocyst culture. Instead of just switching directly over
from day-3 transfers to day-5 transfers they stayed with their normal protocol. Day-3
embryos were transferred and the supernumerary embryos were cultured for 2 or 3 days
further. The embryos that developed to day-6 blastocysts were cryopreserved. This
ensured that the culture system employed was able to support blastocyst development
without compromising day-3 pregnancy rates, and that a suitable cryopreservation
system was in place for when the move to fresh blastocyst transfer was accomplished.
Culture System Optimization
An optimal culture system must be in place to achieve the best embryonic
development in vitro. Many people find it unethical to perform research on human
embryos and it is illegal in most states so an animal model is utilized to form a human
IVF culture protocol. Ackerman et al. (1984), Saito et al. (1984) and Dandekar and
Quigley (1984) reported the in vitro development of mouse embryos is the most
commonly used animal model for quality control of culture media and toxicity testing of
materials used for human IVF. Davidson et al. (1988a) agreed that this method allows
for the detection of factors that may adversely affect the growth of human embryos in
vitro and offers an opportunity to determine optimal culture conditions. Behr and Wang
(2004) listed important components of a culture system that included types of incubation
chambers, O2 levels, oil versus open culture, volume of medium, embryonic density and
time of gamete co-incubation during the insemination period.
The regulation of temperature, humidity and gas phase is an important aspect in
culturing IVF-derived embryos. Trounson (1982) reported the ideal temperature to
maintain human oocytes and embryos in culture is 37°C to 37.5°C. Also, short periods of
handling oocytes and embryos at 21°C to 25°C appear to have no effect on their
cleavage rates. In an earlier study, Trounson et al. (1976) showed that reducing
temperatures to 4°C proved to be deleterious to pig embryos and early cleavage stage
cattle embryos. However, when investigators from the same group reduced
temperatures to 4°C for a few human embryos to evaluate their sensitivity to cooling they
found that embryos continued development in vitro after cooling.
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Trounson (1982) has stated that if oil is not used to cover the embryos during
culture, then 100% humidity is not maintained, which is necessary to maintain the correct
osmolarity of culture medium. A humid chamber was recommended to ensure that the
culture medium (with or without oil coverage) does not evaporate when the incubator
used is unable to achieve the correct humidity level.
Trounson (1982) also reported that when using bicarbonate-based culture media,
a 5% CO2 gas phase must be maintained to control the pH. Human pregnancy rates
were similar after using 5%, 10% and 20% O2, so the use of 5% O2 as a standard
remains debatable.
Although there have been advances in producing in vitro-derived embryos, most
of the commonly used culture techniques have not changed, resulting in unchanged
implantation rates since the 1980s. The majority of human embryos produced through
IVF have been transferred between days 1 and 3 because past culture systems were
unable to support adequate embryo development to the blastocyst stage. As new culture
systems are incorporated into the human IVF clinics, more day-5 and day-6 human
blastocysts are now available for transfer.
Once an acceptable culture system is in place, there still remains the possibility of
poor blastocyst development due to endotoxins in the medium. Fishel et al. (1988)
defined these endotoxins as complex phospholipid-polysaccaride-protein
macromolecules released after the death of bacterial cells. These endotoxins are
associated with gram-negative bacteria and can be found in the cell wall of the bacteria.
These endotoxins are released after either natural autolysis or artificial disruption. One
of the most common types of endotoxins is found in the form of saprophytic gramnegative bacilli that grow in the water used for culture media. The problem is these
endotoxins are heat stable and most often are not destroyed by autoclaving.
Jones et al. (1982) commented on the improved pregnancy rate in their human
IVF-ET program after more stringent quality control was applied in their laboratory
procedures. Similarly, Fishel et al. (1988) emphasized that maintaining high quality
control in a human IVF laboratory was essential for consistent success. Previously,
Fishel and Jackson (1986) described many of the problems associated with the culture of
human embryos in vitro. After noticing fluctuations in the in vitro culture results of their
own clinical IVF cycles over a period of time, Fishel et al. (1988) conducted a thorough
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investigation and found the culture medium as a source of contamination. They detected
endotoxins in the culture medium. The problem appeared when an increased number of
cytoplasmic fragmentation began to show up in the embryo. To explore the cause of
these abnormalities batches of culture medium were tested proceeding, during and
immediately after use for the presence of endotoxins.
In addition, Fishel et al. (1988) tested manufacturer-supplied 1X and 10X
concentrates of Earle’s culture medium in liquid form, homemade Earle’s culture
medium, the on-site Milli Q (water purified to between 17 and 18 MQ) and reverse
osmosis water (Millipore). Paraffin source, pyruvate and penicillin were also tested for
endotoxins. They demonstrated that concentration of endotoxins at >1 ng/ml significantly
reduced the overall number of oocytes fertilized, but there was no observable effect if the
level of endotoxin was <1 ng/ml. The most surprising finding was the level of endotoxins
in the culture medium supplied by a major culture media manufacturer. The 1X culture
medium had an endotoxin level >0.5 ng/ml and the 10X culture medium had a level of 1
ng/ml. Tap water that had passed through the Millipore reverse osmosis system and
was stored in a 90-liter tank also was positive to 0.1 ng/ml, but further purification
through the deionizers and ultrafiltration unit before use reduced this to undetectable
amounts.
Researchers have reported abnormalities in developing embryos due to the
presence of endotoxins in the culture medium. Silver (1981) investigated the effect of
Escherichia coli and demonstrated irreversible damage to cells within 10 minutes of
exposure to endotoxin. Fishel et al. (1988) have reported that the human embryo results
in increased fragmentation, along with irregular membrane patterns and granular
cytoplasm in the presence of endotoxin. Silver (1981) and Snyman and Van der Merwe
(1986) have shown endotoxins damaging internal cell organelles, such as endoplasmic
reticulum, the cristae of the mitochondria, detachment of ribosomes, granulation of the
nucleus and leakage of the cytoplasm. In contrast, Fishel et al. (1988) suggested that
endotoxins do not affect fertilization rate. Reduced incidence of fertilization did not occur
in endotoxin-positive medium as compared with endotoxin-negative medium, and
cleavage occurred at a similar rate in both media after fertilization. It was concluded that
endotoxin contamination may be more obvious from the irregularity and appearance of
blastomeres and the degree of cytoplasmic fragments.
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Bovine In Vitro Fertilization (IVF)
Many of the same requirements that are essential in the survival and transfer of
human embryos are necessary for the culture and transfer of bovine embryos. However,
the reasons for bovine IVF procedures vary from those of humans, whose problems are
mainly caused by infertility. First and Parish (1987) reported that the reasons for
developing systems for fertilization and development of bovine embryos in vitro were for
the production of a large number of genetically superior offspring and the production of
transgenic animals.
Similar to human IVF culture, First and Parish (1987) emphasized that for
ruminants, sperm concentration, time of sperm-ovum interaction, medium utilized and
temperature play a role in successful fertilization, resulting in developmentally competent
embryos. One of the main reasons for failure of fertilization occurring in an in vitro
system is the occurrence of polyspermy. In vivo, oocytes encounter a much smaller
number of sperm at the time of fertilization and have more time to express blocks to
polyspermy. The time that sperm and oocytes are allowed to interact in vitro becomes
important because early blocks to polyspermy in mammalian oocytes may not occur as
rapidly as in invertebrates (see reviews by Wolf, 1981; Shapiro, 1981) and the block to
polyspermy is reduced in aged oocytes (Hunter, 1967). Furthermore, Leibfried-Rutledge
et al. (1987) reported in vitro matured oocytes may not develop the block to polyspermy
to the same effectiveness as in vivo matured oocytes. Therefore, sperm concentrations
and time of sperm-oocyte interaction should both be controlled to minimize polyspermy
(First and Parrish, 1987).
Medium composition and temperature can effect maturation and culture, as well
as influence fertilization success. Parrish et al. (1985) and Susko-Parrish et al. (1985)
have shown that glucose blocks bovine sperm capacitation. First and Parrish (1987)
reported in vivo fertilization occurs at core body temperature, which is 38°C to 39°C for
cattle, 39°C for sheep and 38°C to 39°C for goats. In cattle, Lenz et al. (1983) have
reported in vitro fertilization frequencies are very dependent on temperature, and highest
frequencies occur at 39°C. First and Parrish (1987) suggested that temperature not only
controls efficiency of capacitation but also the ability to undergo a physiological
acrosome reaction in response to interaction with the zona pellucida.
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In early studies, Thibault (1966) reported that the culture of in vitro-produced
bovine embryos led to their arrest at the 8- to 16-cell stage. Over the years this
observation has been explained as the inability of in vitro conditions to allow expression
of the embryonic genome, since the bovine embryo has been found to be
transcriptionally activated near this time (Barnes and Eyestone, 1990), with resulting
changes in patterns of protein formation (Frei et al., 1989). Rexroad (1989) and Bongso
et al. (1990) reported various somatic cells could be used in embryo co-cultures and in
conditioned medium (Eyestone and First, 1989) to overcome arrested development in
vitro. Rexroad (1989) and Eyestone and First (1989) indicated that the positive impact of
somatic cell co-cultures on bovine embryo development was attributed to transfer of
embryotrophic factors and/or reduction of embryotoxic factors in the medium.
There are a variety of methods used for culturing bovine embryos. These include
the co-culture system with somatic cells, such as oviduct epithelial cells (Eyestone and
First, 1989; Ellington et al., 1990; Aoyagi et al., 1990; Fukui, 1990; Kim et al., 1990;
Saeki et al., 1990), uterine fibroblasts (Voelkel et al., 1985; Ellington et al., 1990),
cumulus cells (Goto et al., 1988; Aoyagi et al., 1990; Fukuda et al., 1990; Younis and
Brackett, 1991) and trophoblastic vesicles (Camous et al., 1984; Heyman et al., 1987;
Pool et al., 1988; Aoyagi et al., 1990). However, Bavister et al. (1992) pointed out that
under these culture conditions the portion of inseminated oocytes that develop to the
morula or blastocyst stage ranges from 25% to 40%.
It should not be overlooked that Bavister et al. (1992) stressed that co-culture
systems using somatic cells was a complex culture medium, which usually contains
blood serum, that makes it difficult to analyze the factors involved in embryo
development. Keskintepe et al. (1995) indicated that to understand the requirements for
oocytes going through maturation, the fertilization process and then to uterine-stage
embryos, all unknowns should be eliminated from supporting chemical and physical
culture conditions.
Over the years there have been difficulties developing IVF procedures for farm
animals. The first IVF calf was produced in 1982 (Brackett et al., 1982) followed by the
production of goat (Hanada, 1985), sheep (Cheng et al., 1986), pig (Cheng et al., 1986)
and horse (Palmer et al., 1991) IVF-derived offspring. First and Parish (1987) were
among the first to compile data indicating that the efficiency of producing in vitro offspring
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was less than that achieved by natural mating. Their results showed that ~10% of the
bovine oocytes produced IVF-derived offspring. They also indicated that the most
limiting step in the process was the inefficiency of development of embryos in vitro from
the pronuclear to the blastocyst stage. For immature bovine oocytes recovered from
small follicles (1 to 5 mm in diameter) an additional limitation was the failure to acquire
competence for development to the pronuclear stage (Leibfried-Rutledge et al., 1987).
Staigmiller and Moor (1984) and Critser et al. (1986) concluded that immature oocytes
can obtain embryo developmental competence by co-culturing with abundant preovulatory granulosa or cumulus cells, which receive FSH, LH and estradiol priming.

Defined Culture Systems of In Vitro-Produced Mammalian Embryos
The energy requirements of bovine embryos during cleavage stages have not
been fully defined (Rexroad, 1989; Rieger, 1992), in part, because of the 8- to 16-cell in
vitro developmental block (Thibault, 1966; Brackett et al., 1982; Camous et al., 1984;
First and Parrish, 1987; Aoyagi et al., 1990; Keskintepe et al., 1995). In addition, media
commonly used for bovine embryo culture are complex, usually containing up to 20%
serum (Wright and Bondioli, 1981). Fukui et al. (1991), Pinyopummintr and Bavister
(1991), Takahashi and First (1993), Shamsuddin et al. (1994) and Goto et al. (1994)
have eliminated somatic cells as components of the embryo culture system; however,
they did not replace the bovine serum or bovine serum albumin (BSA) in maturation,
fertilization or the culture medium, and these components contain unknown factors that
contribute beneficial effects on the embryos (Brackett, 1981). Larson et al. (1992) and
Goto et al. (1994) have reported improved viability of uterine-stage bovine embryos
produced in vitro in co-culture-free medium by achieving similar successful embryo
transfer rates yielding offspring.
The development of defined bovine embryo culture systems holds promise for
ongoing efforts in reproductive physiology and for utility in the embryo transfer industry
(Keskintepe and Brackett, 1996). Although a variety of embryo culture systems are used
for in vitro embryo production adequate definition to assure quality control and
repeatability is still lacking. Eliminating culture medium variability would lead to better
understanding of embryo development and thus, over the years attempts have been
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made to simplify (Pinyopummintr and Bavister, 1991; Kim et al., 1993; Brackett and
Keskintepe, 1994; Rosenkrans and First, 1994; Goto et al., 1994, Keskintepe et al.,
1995; Eckert and Niemann, 1995).
When evaluating new culture systems, it is ideal to be able to perform multiple
tests on the same batch of culture medium. However, IVF clinic regulations (Gerrity et
al., 1992; McLendon, 1992) and proposed recommendations (Purdy, 1982; Quinn et al.,
1984) on the amount of time embryo culture media can be stored have been
implemented over the years of a shelf life of no longer than 2 weeks at 4°C for human
IVF culture. Researchers have disagreed with this shelf life time restraint and have
suggested using refrigerator-stored or frozen-stored culture media to increase the
opportunity for more tests to be conducted on a single batch of medium (Naz et al., 1986;
Bernart et al., 1990; De Silva, 1993; Bell et al., 1995). The advantages of media stored
for extended periods of time include reduced variability by using one tested batch of
medium, more efficient and less costly embryo production, availability of cross-testing
and increased number of assays performed could facilitate a more defined human IVF
culture system.
Using laboratory animals, Bavister et al. (1992), Trounson (1992) and Gardner
(1994) have helped define in vitro conditions and increased the understanding of
molecular mechanisms that promote or impede early embryo development. Amino acids
(Rosenkrans et al., 1989; Zhang and Armstrong, 1990; Kim et al., 1993; Rosenkrans and
First, 1994; Keskintepe et al., 1995; Miyoshi et al., 1995), energy substrates (Takahashi
and First, 1992; Rosenkrans et al., 1993;), citrate (Gray et al., 1992; Keskintepe et al.,
1995) and vitamins (Kane and Bavister, 1988a, 1988b; Takahashi and First, 1992;
Rosenkrans and First, 1994), to name a select few, have been shown to profoundly
influence embryonic development in vitro.
Amino Acids
Amino acids play an important role in mammalian IVF culture as energy
substrates, osmolytes, regulators of pH and enzyme activity, scavengers of free radicals,
chelators of heavy metals, precursors of macromolecules such as proteins and nucleic
acids and mediators of transport across the cell membrane (Bavister, 1995; Liu and
Foote, 1995; Lee and Fukui, 1996). However, the beneficial effects can be restricted to
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certain amino acids (Bavister, 1995; Steeves and Gardner, 1999) and may be affected
by the base medium (Van Winkle and Campione, 1996).
Kane et al. (1986) reported that development of hamster embryos in vitro is
enhanced by the addition of amino acids and vitamins. In a classic study, Carney and
Bavister (1987) found that development of hamster embryos was increased when 20
amino acids were added to Tyrode’s albumin-lactate-pyruvate (TALP) medium.
Furthermore, they noted that the addition of glutamine alone to be as good as or better
than the addition of the 20 amino acids or various combinations of amino acids. Meyen
et al. (1989) reported the opposite results with pig embryos, stating that these embryos
may have retarded in vitro development in the presence of minimum essential medium
(MEM) or basal medium Eagle (BME) with amino acids. However, Stone et al. (1984),
Rosenkrans et al. (1989) and Hagen et al. (1991) reported normal development of pig
embryos with free amino acids in the culture medium. With bovine embryos, Takahashi
and First (1992) reported that development improved when both BME essential and
MEM nonessential amino acids were added to a modified synthetic oviduct fluid medium
(mSOF).
Rosenkrans et al. (1989) evaluated the effects of glutamine, methionine,
phenylalanine and isoleucine on pig embryo development. The reason these particular
amino acids were chosen for this study is because Bavister et al. (1983) noted
improvement in hamster embryo development in vitro when these amino acids were
added to the culture medium. Gwatkin and Haidri (1973) had previously reported that of
the 13 amino acids in MEM, glutamine, methionine, phenylalanine and isoleucine were
the most critical for in vitro maturation of hamster oocytes. In his study, Rosenkrans et
al. (1989) added these four amino acids with the presence of serum and with the
absence of serum in the culture medium. The results indicated that in the presence of
10% lamb serum the addition of phenylalanine, methionine and isoleucine significantly
improved blastocyst expansion, but when lamb serum was omitted, addition of the same
three amino acids was detrimental to embryo development. It was found that glutamine
was detrimental to pig embryos in the presence of serum but beneficial when the culture
medium did not contain serum. Methionine was beneficial to pig embryos in the absence
of serum and was the only factor that increased the number of cell nuclei per embryo.
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These porcine embryo findings suggested that it is obvious that other factors are
required by pig embryos that were not evaluated in this experiment (Rosenkrans et al.,
1989). Thus serum likely contains those unknown components, including nutrients and
growth factors. However, even in the presence of serum there is still a difference in the
development of in vitro-produced compared with in vivo-produced pig embryos. Similar
retardation patterns of in vitro-produced embryos have been recognized for the embryos
of other animal species (Bavister, 1987). Until researchers are able to fully understand
and duplicate the exact conditions provided by the reproductive tract of mammals during
early pregnancy these developmental inhibitions will remain present.
It has been proposed over the years that embryo requirements for amino acids
change according to the developmental stage. Kim et al. (1993) found almost no
development of bovine 1-cell embryos to the blastocyst stage when mTLP-PVA without
amino acids was used, whereas, 9% to 13% of the embryos developed when the
medium (glucose-free) was supplemented with 18 amino acids (all contained in HECM)
and with one extra amino acid (L-tyrosine) but without taurine and glutamine, at low
concentrations (0.02 - 0.2 mM). Takahashi and First (1992) also reported that
supplementation of 20 amino acids to a chemically semi-defined medium with BSA
markedly improved development of bovine 1-cell embryos to the morula stage. Kim et al.
(1993) noted these findings indicate the importance of amino acids for in vitro
development of bovine embryos. It was previously shown that the uptake of amino acids
increases from the 8-cell to the blastocyst stage in mouse embryos (Brinster, 1971). In
addition, amino acids have also been found to be a requirement for in vitro development
of hamster (Bavister et al., 1983; Carney and Bavister, 1987; Kane and Bavister, 1988b),
rabbit (Daniel and Olson, 1968; Kane and Foote, 1970), rat (Zhang and Armstrong,
1990), pig (Rosenkrans et al., 1989) and sheep (Zhang and Armstrong, 1990) embryos.
To further support the idea that amino acid needs are different at different stages
of embryo development, Schini and Bavister (1988) and Seshagiri and Bavister (1991)
showed that with the chemically defined medium HECM containing 20 amino acids,
development of hamster 2-cell and 8-cell embryos to the morula and blastocyst stages
can be obtained. However, Bavister and Arlotto (1990) reported that hamster 1-cell
embryos are inhibited from development past the 4-cell stage in this medium, showing
that a group of amino acids inhibit the development in vitro.
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Rosenkrans and First (1994) evaluated the effect of free amino acid and vitamin
supplementation to developing bovine embryos cultured in CR1aa medium. A claim was
made that this was the first report demonstrating an additive effect of the fibroblast
essential amino acids (EAA) and nonessential amino acids (NEA) on embryo
development. The results of the study concluded that the addition of BME and MEM
amino acids to CR1 increased the developmental rate of bovine zygotes in vitro. This
1994 paper designated the use of CR1 medium with EAA and NEA as CR1aa. In a
previous paper, Monson et al. (1992) reported that bovine embryos developed in the
basic CR1 medium established pregnancies as well or better than embryos developed in
co-culture with oviductal cells after transfer to recipient cows. Betteridge and Flechon
(1988) suggested that the increased morula to blastocyst ratio with the addition of amino
acids to the culture medium was similar to that of in vivo production. Takahashi and First
(1992) reported that the addition of both EAA and NEA to mSOF increased the cell
number of bovine IVF blastocysts.
Rosenkrans and First (1994) proposed that amino acids were likely acting as
energy substrates, pH regulators and/or as a pool for de novo protein synthesis. This
study showed the amino acid composition of NEA and EAA with glutamine (1mM)
increased the development of bovine embryos in vitro regardless of the mechanism(s)
involved by the amino acid(s).
Glucose and Phosphate
Pinyopummintr and Bavister (1991), using a chemically defined medium (HECM)
containing 20 amino acids but not pyruvate, protein, glucose and phosphate, reported
that blastocyst development of bovine embryos was depressed in the presence of
glucose and phosphate when compared with phosphate alone. They reported 13.8% of
embryos in TCM-199 containing both glucose and phosphate, the same percentage of
embryos (14.3%) as that for HECM with phosphate developed to the blastocyst stage in
the same experiment. Kim et al. (1993) indicated this inconsistency makes it difficult to
explain the exact role(s) of glucose and phosphate in chemically defined media. Bovine
blastocyst development was greatly inhibited in the presence of glucose, regardless of
the presence of phosphate, in a simple, chemically defined, protein-free medium (mTLPPVA) with 19 amino acids, lactate and pyruvate. Schini and Bavister (1988) obtained
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contrasting results using hamster 2-cell embryos cultured in chemically defined medium
(HECM).
In both species (hamster and cattle) culture inhibition from glucose did not occur
in the absence of phosphate (Schini and Bavister, 1988; Pinyopummintr and Bavister,
1991). However, in a chemically semi-defined medium with phosphate, the deleterious
effect of glucose (when present throughout culture) has been reported on bovine
(Takahashi and First, 1992) and ovine (Thompson et al., 1992) embryo development to
the morula or blastocyst stage. In contrast, Javed and Wright (1991) and Rieger et al.
(1992) indicated that the embryonic metabolism of glucose markedly increased in the
bovine embryo from the 2-cell stage to the blastocyst in bovine embryos. However,
Rieger and Loskutoff (1994) reported that cumulus-enclosed bovine oocytes utilize
glucose and pyruvate during the first 18 hours of their in vitro maturation in preference to
glutamine, and glutamine metabolism is amplified 18 hours after the beginning of
maturation.
Takahashi and First (1992) and Wang et al. (1990) have reported that when
glucose was added in various concentrations to synthetic oviduct fluid or conditioned
medium, bovine embryo development decreased as the concentration of glucose
increased. Rosenkrans et al. (1993) found that the development of bovine embryos was
inhibited when glucose was added to the CR2 medium. CR2 medium consisted of
sodium chloride (109.5 mM), potassium chloride (3.1 mM), calcium chloride (2.5 mM),
magnesium sulfate (0.5 mM), sodium bicarbonate (26.2 mM) and EDTA (0.01 mM) with 3
mg fatty acid-free BSA per ml. This inhibition of development occurred even in the
absence of exogenous phosphate. These data contradict the results of others (Schini
and Bavister, 1988; Pinyopummintr and Bavister, 1991) indicating that the inhibitory
effect of glucose on bovine and hamster embryo development occurred only in the
presence of phosphate. However, it should be noted that the composition of the base
medium in those studies was different from that of Rosenkrans et al. (1993).
Lactate and Pyruvate
Kim et al. (1993) reported that when lactate (10 mM) and pyruvate (0.5 mM) were
omitted from mTLP-PVA containing 0.35 mM phosphate and amino acids, the first
cleavage of bovine 1-cell embryos was completely inhibited in the chemically defined
condition used. However, when supplementing the two substrates alone, each could
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equally support the development of bovine 1-cell embryos. The individual substrates not
only supported these bovine embryos to the 2-cell stage but also to the blastocyst stage
as well. Although McKiernan et al. (1991) reported that pyruvate was inhibitory to the
development of hamster 1-cell embryos, previous investigators have reported no such
inhibitory effect on development of bovine (Takahashi and First, 1992) and ovine
(Thompson et al., 1992) 1-cell or 2-cell embryos to the morula or the blastocyst stage in
chemically semi-defined media with serum albumin.
The energy requirements of murine embryos have been studied extensively
(Quinn and Wales, 1973; Cross and Brinster, 1973; Chatot et al., 1989; Lawitts and
Biggers, 1991a); however, few reports have been published on energy metabolism by
embryos from domestic farm animals (Rieger et al., 1992). Rosenkrans et al. (1993)
evaluated the pyruvate and lactate requirements of bovine embryos in vitro. Rosenkrans
et al. (1993) reported that in a simple medium (serum-free) the addition of pyruvate does
not appear to be necessary for in vitro development of bovine embryos when L-lactate
was present. They also reported that when pyruvate was added as the only energy
substrate, concentrations greater than 1 mM decreased the percentage of embryos
developing to the blastocyst stage. These results are in agreement with those of Cross
and Brinster (1973) when they cultured mouse zygotes. Cross and Brinster (1973)
suggested that bovine embryos appear to be more tolerant of increased concentrations
of L-lactate than of pyruvate, but less tolerant of lactate concentration than murine
embryos. Rosenkrans et al. (1993) indicated that the use of L-lactate in preference to
pyruvate is associated with the conversion of L-lactate to pyruvate by lactate
dehydrogenase (LDH). Results reported by Johnson et al. (1991) suggested that LDH
could be used as an indicator of bovine embryo viability.
Chatot et al. (1989) and Cross and Brinster (1973) indicated that a lactate:
pyruvate ratio approaching 120 was optimal for in vitro development of murine embryos.
For bovine embryos, the results of Rosenkrans et al. (1993) suggested that the lactate:
pyruvate ratio was less important than the total lactate or pyruvate concentration. The
primary controller appears to be the lactate concentration when both lactate and
pyruvate are added to the medium.
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Vitamins
There is very little information available to date on the role of vitamins for embryo
development, but it is probable that their role in embryos is generally similar to their role
in mammalian cells (Kane and Bavister, 1988a). Hawthorne (1982) and Vance (1986)
reported inositol is essential for the synthesis of certain membrane phospholipids in cells
and it is possible that at the blastocyst stage it becomes necessary for the synthesis of
phospholipid components of new membranes.
Kane et al. (1986) showed that the addition of amino acids and a group of 11
water-soluble vitamins and growth factors from Ham’s F-10 medium to a simple medium
containing bovine serum albumin stimulated development of 8-cell and morula stage
hamster embryos to hatching blastocysts in vitro, but hatching was delayed when
compared with the in vivo development. In a subsequent study, Kane and Bavister
(1988a) examined which of 11 water soluble vitamins stimulated hamster embryonic
development at the blastocyst stage. This question is of particular interest because there
is only one other mammalian species (the rabbit; Kane, 1988) for which this information
is available. Of the 11 vitamins only two showed the effects of successive addition to the
culture medium, which was a modified Tyrode’s solution (TLP-PVA, Bavister et al., 1983;
Boatman, 1987) without phenol red supplemented with amino acids. The two vitamins
that showed a difference in development with their addition to the culture medium were
inositol and choline.

Frozen Storage of In Vitro Culture Media
The quality of the culture medium is a crucial factor influencing the success of
IVF/IVC human oocytes and embryos in a program for infertility treatment (Jones et al.,
1982; Purdy, 1982; Trounson, 1982; Dandekar and Quigley, 1984; Quinn et al., 1984;
McDowell et al., 1988). Therefore, Purdy (1982), Trounson (1982) Vijayakumar et al.
(1987), Naaktgeboren (1987), Davidson et al. (1988a, 1988b) and McDowell et al. (1988)
have recommended the performance of an assay for mammalian embryo culture to
evaluate the suitability of the medium before using it for human IVF. Purdy (1982) and
Quinn et al. (1984) proposed that a preparation of culture medium stored at 4°C for
longer than 1 to 2 weeks should not be used for human IVF. Also, guidelines have been
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set by the American Fertility Society (AFS) for ART programs (Gerrity et al., 1992) and
the College of American Pathologists (CAP) (McLendon, 1992) to ensure clinics adhere
to this storage time limit. It takes 4 to 5 days for the results of the embryo culture assay
to be evaluated in all of the available test models. Therefore, only a few days are left
after the test for the medium to be used. Due to the limited storage period (shelf life), no
time is available to repeat an assay yielding unclear results or to cross-test with other IVF
laboratories.
The maintenance of a high quality culture system for human IVF is a difficult task
for laboratory technicians. The quality of the chemicals and the water used for media
preparation can vary from batch to batch and influence the outcome of human IVF
procedures (Codon-Mahony et al., 1985; Vijayakumar et al., 1987; Yovich et al., 1988).
Even minimal contamination of the medium, for example with endotoxins (Snyman and
Van der Merwe, 1986; Fishel et al., 1988) or with surgical glove coating (Naz et al., 1986)
has been reported to reduce the pregnancy rates after embryo transfer.
Bernart et al. (1990) proposed that fertilization of the oocyte and the first 2 or 3
cleavage steps are almost uninfluenced by subtle changes in culture medium quality.
Leung et al. (1984), Grillo et al. (1987) and Fishel et al. (1988) indicated that the
“morphological quality” of the embryos at the time of the embryo transfer (usually in the
4-cell stage) gives very little information relating to the chance of embryo implantation.
Bernart et al. (1990) reported that subtle damage to embryos often does not occur before
the human morula or blastocyst stage, 2 to 3 days after the day of embryo transfer.
In a pilot study, Curole et al. (1988) placed “spare” human embryos in culture up
to the blastocyst stage. This procedure provided information related to the quality of the
culture system, but such an “assay” performed during routine IVF work can obviously
caused ethical and/or legal concerns. Quinn et al. (1984) demonstrated how essential it
was for an IVF clinic to have a reliable quality control system in an animal model. Since
some test models fail to detect subtle changes in medium quality several authors
(Davidson et al., 1988a, 1988b; Fleetham and Mahadevan, 1988; Rinehart and Bavister,
1988) reported it would be very useful to have the media cross-tested between different
IVF laboratories before using them on human IVF. With the recommended storage
period at 4°C of 1 to 2 weeks, there is little time available for these extensive tests
(Purdy, 1982; Quinn et al., 1984; McLendon, 1992; Gerrity et al., 1992).
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With such a limited storage time for the use of culture media, IVF directors are
faced with complications that accompany this restraint. Preparing culture medium every
2 weeks can be time consuming and expensive, but viewed as necessary to operate a
successful IVF program. It has been suggested that this 2-week storage limitation is
unnecessary and no developmental decrease is seen with in vitro-produced embryos
cultured in media stored for longer periods of time (Naz et al., 1986; Bernart et al., 1990;
De Silva, 1993; Bell et al., 1995). Naz et al. (1986) showed that storing Ham’s F-10
medium for up to 425 days at 4°C did not affect 2-cell mouse embryo development to
blastocyst culture. However, the 2-cell mouse embryo may not be sensitive to subtle
changes in the culture medium and, therefore, may not have detected any differences
between the freshly prepared and the stored medium (Silverman et al., 1987; Davidson
et al., 1988a).
When freezing culture media it must be taken into account that Na+ solutions tend
to precipitate after freezing and thawing. In most embryo culture media almost the entire
source of osmolarity comes from the Na+ concentration. Most of the time, increased
osmotic pressure is a direct affect of increased Na+ levels. However, extracelluar Na+
can affect intracellular pH via its effect on the Na+/H+ anti-porter (Lane and Bavister,
1999). High NaCl concentrations and or osmotic pressure of a medium can affect the
development of embryos in vitro. Summers et al. (1995) indicated lower osmotic
pressure and a reduction in NaCl concentration were partially responsible for the
improved development of mouse embryos in KSOM. Lim et al. (1994) and Liu and Foote
(1996) recommended reducing the osmotic pressure of bovine culture media to <270,
however, the most widely used human culture media (SOF, TCM-199, CR1) have higher
osmotic pressures than this.
Van den Berg and Rose (1959) reported the negative effect of temperature in the
freezing zone on pH and composition of potassium and sodium phosphate solutions is a
result of salt and ice precipitation. Previous studies by Lovelock (1953a, 1953b) and
Lovelock and Polge (1954) showed that the damage suffered by erythrocytes and
spermatozoa was related to the sodium chloride concentration reached in the
suspension during freezing, causing increased attention to be focused on the effect of
salts during freezing. As sited by Van den Berg and Rose (1959), Finn (1932) showed
that the pH of the liquid portion of frozen muscle juice decreased with temperature below
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the freezing point and that denaturation of muscle juice proteins reached a maximum at
temperatures when the pH was below 6.0 with a salt concentration in the solution of
around 0.8 M. Previously, Harvey (1918) found that the pH of cabbage juice decreased
during freezing (see Van den Berg and Rose, 1959). Subsequently, Tessier and Rose
(1956) noted that the pH of milk ultrafiltrate changed from 6.7 to 5.8 during freezing (see
Van den Berg and Rose, 1959). They suggested that such a pH change could decrease
the stability of the casein of frozen milk. Rey (1957) stated that when temperature is
lowered in addition to an increase in salt concentration, pH changes may occur and
affect the material being frozen. Van den Berg and Rose (1959) indicated that since the
pH of solutions depends on composition and precipitation of either ice or salt, then
freezing should affect the pH.
Van den Berg and Rose (1959) showed that substantial changes in pH and
composition occur in buffer solutions of sodium and potassium phosphates during
freezing, depending on initial pH and relative contents of sodium and potassium. In
another study, Van den Berg (1959) indicated that biological materials contain other salts
in addition to sodium and potassium phosphate, and these also may have appreciable
effects on pH changes during freezing. Sodium and potassium chlorides occur most
frequently among these additional salts and are usually present in relatively large
concentrations. However, Lovelock (1953b), Lovelock and Polge (1954), Harrison
(1956) and Lusena and Rose (1956) have stated that biological material is often frozen in
the presence of sodium chloride.
Van den Berg (1959) also reported the pH and composition of the solutions from
which both sodium and potassium phosphate are precipitating, either with or without a
chloride, as well as the freezing points of these same solutions. Thus, within the pH
range of 3.3 to 7.5, a complete range was given of the changes that may occur in pH,
composition and freezing point of mixed solutions of sodium, potassium, phosphates and
chlorides. Van den Berg (1959) indicated that the addition of either sodium or potassium
chloride to material buffered with phosphates may cause marked changes in pH during
freezing. Lea and Hawke (1952), Harrison (1956) and Lovelock (1957) indicated that
such changes will significantly alter the stability of frozen biological materials. Van den
Berg (1959) suggested that buffer solutions in which biological materials are to be frozen
should, therefore, be chosen so as to minimize these pH changes.
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Since the stability of colloid systems depends on pH, as well as, ionic strength of
the solution in which they were suspended, pH changes, such as were demonstrated in
the phosphate solutions, are likely to affect the stability of various biological systems
such as, erythrocytes, spermatozoa and bacteria during freezing (Van den Berg and
Rose, 1959). Given that the development of acidity during freezing is harmful, the use of
a high potassium buffer may be beneficial.
Van den Berg and Rose (1959) also have indicated that supersaturation may
cause only temporary changes in pH. Large degrees of supersaturation for one or more
salts occurred frequently and were sometimes maintained for several hours or even days
even though freezing mixtures were seeded. They reported these metastable states did
not affect the pH and composition of the stable state finally reached, but they
represented temporary changes in pH and composition that may be important in the
freezing of biological materials.
Lopata et al. (1980) and Purdy (1982) described methods of freezing and storing
concentrated stock solutions of culture media for IVF. The disadvantage with these
methods when used for culture is the addition of water to the post-thaw medium. Once
water is added the pH and osmolarity of the medium must be re-adjusted and another
quality test in the animal model has to be performed after the preparation of the “readyto-use” medium.
Bernart et al. (1990) investigated a very easy method of frozen storage of Ham’s
F-10 medium for several months. The results provided “ready-to-use” culture medium for
human IVF without having to re-adjust and test the medium after thawing. Two
application models were used; an animal IVF model and a human IVF model. In the
storage process, separate aliquots of 33 ml of Ham’s F-10 stock solution and 1 ml
aliquots of sodium bicarbonate stock solution were frozen at -20°C. They explained the
bicarbonate must be frozen and stored separately, because if not components of the
medium precipitate out during the freezing–thawing process.
Bernart et al. (1990) cultured 2-cell stage mouse embryos in fresh medium
(control) and in medium frozen for 2 weeks, 1 month, 2 months, 4 months and 6 months,
respectively. The developing embryos were then evaluated for expanded blastocyst and
hatched blastocyst rates. After the test series in the mouse model, two different IVF
centers (University Women’s Hospital of Heidelberg and Municipal Women’s Hospital of
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Darmdstadt) applied the frozen-thawed medium to human IVF. Bernart et al. (1990)
collected data from three subgroups where different periods of frozen storage medium
(up to 1 month, 1-2 months, 2-3 months) were evaluated and compared with the results
of cycles in which non frozen culture medium was used (storage at 4°C for up for 5
days). In both the animal and human culture models, there was no significant difference
between the subgroups cultured in fresh medium compared with medium stored frozen
for various time intervals. These results showed that there is no loss of stability of the
frozen-stored Ham’s F-10 medium within the tested period of 6 months for the animal
model and 3 months for the human model.
The storage of culture media creates advantages that do not exist with
reproducing stock medium every 2 weeks. A number of batches can be made at the
beginning of each IVF cycle, tested with the 1-cell mouse embryo bioassay and selected
for those batches that perform the best. Those batches can then be properly stored in a
refrigerator at 4°C and subsequently used for human embryo cultures during that cycle.
This would likely minimize variability among culture media and cut down on expenses
and technician time. Also, storage would enable gametes and embryos from a group of
patients to be exposed to the same batch of culture medium.
De Silva (1993) evaluated the effect of storage of Ham’s F-10 medium on 1-cell
mouse embryo development in vitro. Embryos were cultured in one of seven groups;
fresh, 1-, 2-, 3-, 4-, 5- or 6-month old medium, with four to six replicates for each month
of comparison. The percentage of development of small, expanded/collapsed, hatched,
and all (small, expanded/collapsed, and hatched stages combined) blastocysts by 96
and 120 hours after culture was calculated based on the initial number of 2-cells. This
study showed there was no significant difference in embryo development to 2-cells,
whether embryos were cultured in fresh or stored medium. The results also showed that
there was no difference in the development to small, expanded/collapsed, hatched or all
blastocysts either at 96 or 120 hours after initiation of the culture. The findings of this
study indicated that Ham’s F-10 medium can be stored in a refrigerator at 4°C for longer
than the recommended 2-week period without compromising 1-cell mouse embryo
development in vitro. These results are in agreement with two earlier studies (Naz et al.,
1986; Bernart et al., 1990) showing that Ham’s F-10 medium can be stored refrigerated
(4°C) or frozen (-20°C) without affecting 2-cell mouse embryo development in vitro.
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Subsequently, Bell et al. (1995) tested the storage ability of refrigerated Ham’s F10 culture medium in human assisted reproduction programs. The group exposed
human gametes and early pre-implantation embryos to a single preparation of Ham’s F10 medium (2-liters) maintained in refrigerated storage (4°C) for a period of 3 months.
The storage life was measured by the ability of the medium to support fertilization and
early embryos in vitro. Associated implantation rates were used as a later indirect
indicator of the quality of the medium. Patients in the study were separated into two
treatment groups, IVF or ZIFT, determined by respective fertility treatment. The oocytes
and embryos of the IVF patients or oocytes and fertilized oocytes of the ZIFT patients,
were exposed to the same batch of Ham’s F-10 medium stored at 4°C in the dark for
periods of up to 1, 2 and 3 months. They compared the results of 2 and 3 month storage
periods with 1 month storage periods. The fertilization and clinical pregnancy rates
between 1 month storage and 2 and 3 month storage for IVF-ET and ZIFT patients were
not significantly different. Based on these results, Bell et al. (1995) suggested that
reconstituted Ham’s F-10 medium can be stored at 4°C for at least 3 months, since it still
provided adequate support for fertilization and early in vitro development to the human 4cell stage embryo.
Over the past three decades, in vitro embryo culture and transfer has become
increasingly popular among different animal species making it crucial to have an efficient
culture system in place allowing for adequate embryo development. In whatever
species, researchers agree that good quality control in the laboratory is essential to the
success of in vitro fertilization. Most laboratory directors believe to maintain this quality
control a number of assays must be performed on the media before an IVF cycle begins.
Assays are also important in evaluating and determining components that are
detrimental for a defined medium to produce high developmental potential for IVFderived embryos. With the required shelf life of embryo culture medium for human IVF
laboratories being no longer than 1 to 2 weeks stored at 4°C (Purdy, 1982; Quinn et al.,
1984; Gerrity et al., 1992; McLendon, 1992), a problem arises in performing more than
one assay on a single batch of culture medium. Recently, commercial culture media
manufactures have started to investigate the potential of frozen-thawed culture media.
At this stage, there is still very little information available on the stability of culture media
after the freezing-thawing process. Therefore, it is important to evaluate the ability of
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blastocyst development in culture media that has been frozen and/or stored for a period
of time longer than 1 to 2 weeks.
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CHAPTER III
EXPERIMENT I
IN VITRO DEVELOPMENT OF BOVINE EMBRYOS USING FROZEN-THAWED
COMMERCIAL CULTURE MEDIUM AT -20°C
Introduction
Being able to freeze and store embryo culture media would create the possibility
of extending the standard (recommended) shelf life (Purdy, 1982; Quinn et al., 1984;
Gerrity et al., 1992; McLendon, 1992) from 1 to 2 weeks at 4°C to an extended period.
Human infertility clinics make fresh culture media approximately every 2 weeks or
receive shipments of commercial culture medium that is produced on average every 2
weeks.
Over the past century researchers have gone from Albert Brachet’s 1912 blood
plasma culture medium (Brachet, 1912, 1913) to Whitten’s (1957) and Brinster’s (1963)
improved culture conditions that led to the in vitro development of 2-cell mouse embryos.
Although improvements were made, Alexandre (2001) stated it was obvious to the early
researchers that experiments would be hard to reproduce when using a culture medium
such as blood plasma or blood serum, which contained complex unknown components.
Research has continued over the years to develop more defined culture media to help
reduce the variability among laboratories and commercial media.
A primary step in having a successful in vitro fertilization laboratory is having an
efficient embryo culture system in place. There are many factors involved when setting
up a successful in vitro fertilization (IVF) culture protocol. One important aspect is the
evaluation of the culture media before being used. Many researchers suggest using an
animal assay to evaluate results before using embryo culture media for human IVF. It
usually takes 4 to 5 days to complete an assay leaving enough time for only one IVF
cycle with that batch of medium. This restraint permits no time for multiple IVF cycles to
be conducted to compare within a single batch of culture medium.
Many human IVF clinics use animal embryos (e.g., mice) to serve as a reference
model for their human IVF embryos, since it is unethical and in most states illegal to
perform research on human embryos. Once an efficient animal culture protocol is in
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place the human culture system can be monitored using the animal embryo culture
system. Data from both culture systems can be monitored to ensure embryo quality in
the laboratory. The ideal design would be to compare results from the same batch of
culture medium to reduce variation; however, the limited shelf life of the media creates a
problem. One human IVF cycle takes from 3 to 5 days, depending on the embryo stage
at transfer for individual clinics, leaving fresh culture media only available for use in two
cycles.
In addition, comparison of IVF results among clinics is difficult and data
comparing the same batch of medium among a number of different IVF cycles is usually
not available. Over the years, it has been suggested by clinicians that the prescribed 2week storage limitation is unnecessary (Naz et al., 1986; Bernart et al., 1990; De Silva,
1993; Bell et al., 1995). Clinical observations suggest that there is no decreased embryo
development found with in vitro-produced embryos cultured in media stored for time
periods greater than 2 weeks.
Limited research has been reported on the effects of freezing embryo culture
media. Van den Berg (1959), Van den Berg and Rose (1959) and Bernart et al. (1990)
are among the few researchers who studied the effects of frozen-thawed embryo culture
media on embryos or the frozen-thawed viability effects of components in the media.
Van den Berg (1959) demonstrated that pH of the medium could be affected during
freezing by the presence of sodium and potassium chlorides in solutions of phosphates.
Van den Berg and Rose (1959) showed how ice and salt precipitation also could affect
the pH during freezing of solutions of monosodium and disodium potassium phosphates.
Naz et al. (1986) and Bernart et al. (1990) have reported that Ham’s F-10 medium can
be stored refrigerated at 4°C or frozen at -20°C without affecting 2-cell mouse embryo
development in vitro.
The storage of culture media creates advantages that do not exist with
reproducing stock media every 2 weeks. A number of batches can be made at the
beginning of each IVF cycle, tested with the 1-cell mouse embryo bioassay and those
batches selected that yield the best bioassay results. The best batches are then stored
in a refrigerator at 4°C and subsequently used for human embryo cultures during that
cycle. This would minimize variability among culture media and reduce technician time
and expenses. More importantly, cold storage of tested media would enable gametes
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and embryos from a group of patients to be exposed to the same batch of culture
medium increasing laboratory efficiency. This would also increase the number of IVF
cycles exposed to the same treatment for comparison. The benefit would be a better
understanding of the processes of in vitro development without the variability between
different batches of culture media.
The objective of this study was to test fresh and frozen-thawed human
commercial culture medium at -20°C using IVF-derived bovine embryo development.

Materials and Methods
Experimental Design
For this experiment the experimental design originated from the commercial
media company. This experiment was conducted to determine the developmental
potential of IVF-derived bovine embryos cultured in a commercial medium frozen at 20°C and then frozen-stored for various time periods. IVF-derived bovine blastocysts
cultured in frozen commercial medium were compared with IVF-derived bovine
blastocysts cultured in the same fresh medium. Bovine 1-cell zygotes were shipped by
Fedex Priority Overnight courier service to the Louisiana State University Agricultural
Center Embryo Biotechnology Laboratory from a commercial source in a portable
incubator. They were shipped in the afternoon arriving between 10:00 am and 1:00 pm
the next day.
This experiment consisted of three treatment groups: Treatment A was a
laboratory control CR1aa culture medium, Treatment B was a fresh commercial culture
medium stored at 4°C and Treatment C was a frozen-thawed commercial culture
medium frozen from periods of 3 days to 10 weeks before in vitro culture. Treatments A
(n=6 replicates) and B (n=6 replicates) contained a total of 180 zygotes each. Treatment
C (n=6 replicates, with 3 treatments per replicate) contained a total of 1,734 zygotes. For
this experiment, Treatment B medium was recorded as Fresh 0 weeks. Treatment C
was subdivided into six different frozen storage times; Frozen 3 days, Frozen 2 weeks,
Frozen 4 weeks, Frozen 6 weeks, Frozen 8 weeks and Frozen 10 weeks. Frozen
commercial medium had been previously frozen and stored at -20°C for its individual
assigned time period by the commercial media supplier and shipped on dry ice to our
laboratory. Over a period of 3 months 6 trials were performed, each one including a
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group of IVF-derived embryos cultured in media from Treatment A, Treatment B and 3
groups cultured in Treatment C (Appendix D).
Zygotes in each replicate were randomly assigned to each of the three treatment
groups and were cultured in the appropriate culture medium for 4 days. On day 4,
CR1aa culture medium in Treatment A was supplemented with 5% fetal bovine serum
(FBS) and the commercial culture medium was supplemented with 0.5 mM of glucose
(G-6152, Sigma-Aldrich, Inc., St. Louis, MO). Culture was continued until day 8.
Cleavage and blastocyst rates were assessed on day 4 and day 8 of in vitro culture,
respectively, for all treatment groups.
Experimental Procedure
The fresh and frozen human commercial culture medium arrived on ice (wet and
dry, respectively) by FedEx at the Louisiana State University Agricultural Center Embryo
Biotechnology Laboratory (EBL) 1 day prior to its use. The name of this culture medium
can not be disclosed for proprietary reasons, so for this thesis we have assigned a code
name of GX2. Upon arrival, the fresh GX2 medium was stored overnight at 4°C and the
frozen GX2 medium was thawed by placing it in a 37°C water bath then stored overnight
at 4°C.
Zygote Receipt and Preparation for Culture
Bovine zygotes were received from a commercial supplier (BOMED, Inc.,
Madison, WI) in a portable incubator (Minitube®, Minitube America) at 39°C. Zygotes
were shipped in groups of 50 per vial containing Tyrodes lactate HEPES medium (TL
HEPES) and bovine serum albumin (BSA) (see Appendix B). Upon arrival vials were
removed from the portable incubator and stored in a 5% CO2 incubator in humidified air
at 39°C until use. The zygotes were then removed from individual vials and placed into
one Falcon® 35 x 10 mm plastic petri dish containing a TL HEPES medium (04-616F,
Cambrex Bio Science Walkersville, Inc., Walkersville, MD). Two washes were made for
each treatment medium (CR1aa, fresh and frozen-thawed GX2 commercial culture
medium) creating a total of 10 Falcon® 35 x 10 mm plastic petri dishes. All the media
had been previously incubated at 39°C to allow proper temperature and CO2
equilibration. Zygotes were then washed twice in respective treatment medium and 15
zygotes were randomly selected and placed in each 75 µl culture droplet in a 35 x 10 mm
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dish containing the corresponding medium. The number of 1-cell, 2-cell and 2- to 8-cell
embryos were recorded before zygotes/embryos were placed into in vitro culture.
Media Preparation and Use
All chemicals were purchased from Sigma-Aldrich, Inc. (St. Louis, MO) unless
indicated otherwise. The laboratory control culture medium (CR1aa) has been used for
more than 2 years in our laboratory and was prepared as described previously by
Rosenkrans and First (1994). The CR1aa stock solution was prepared by adding 114.7
mM NaCl (S-5886), 1.6 mM KCl (P-5405), 0.39 mM pyruvic acid (P-4562), 26.2 mM
NaHCO3 (S-8875), 2.5 mM L(+)lactic acid (L-4388), 0.5195 mM glycine (G-8790), 0.5051
mM L-alanine (A-7469) and 0.2 ml of 0.5% phenol red per 100 ml of Milli-Q water. The
CR1aa stock solutions were filtered with a 0.2 µm Acrodisc® sterile filter (PN 4612, Pall
Corporation, East Hills, NY) and stored at 4°C for ≤3 months.
The control in vitro culture medium CR1aa for day 1 through day 4 was prepared
weekly by combining 9.5 ml CR1aa stock solution, 2% (v/v) of Basal Medium Eagle
(BME) amino acid solution (50X, B-6766), 1% (v/v) of Modified Eagle Medium (MEM)
amino acid solution (10X, 11140-050, Gibco Laboratories, Grand Island, NY), 50 mg/ml
of gentamycin (15750-060, Gibco Laboratories), 1.1 mM L-Glutamine (G-5763) and 3
mg/ml of BSA (A-7511). Medium was filtered with a 0.2 µm sterile filter (Acrodisc®
Syringe Filters with Supor® Membrane). In Falcon® 35 x 10 mm plastic petri dishes, four
75 µl droplets were made and covered with warmed (39°C) medical grade mineral oil
(330779) then placed in an incubator at 39°C for 45 to 60 minutes to allow medium to
equilibrate.
On the day of use both fresh and frozen-thawed GX2 culture medium was
aliquoted into 20 ml and supplemented with 0.3% of BSA (3 mg/ml, A-7511). No
precipitate was observed in the frozen-thawed medium. The fresh and frozen-thawed
GX2 medium was filtered with a 0.2 µm Acrodisc® sterile filter (PN 4612, Pall
Corporation). Four 75 µl droplets were made with fresh and frozen-thawed medium in
two Falcon® 35 x 10 mm plastic petri dishes for each treatment, covered with warmed
(39°C) medical grade mineral oil and the dishes were then placed in an incubator at 39°C
for 45 to 60 minutes to allow for proper temperature and CO2 equilibration.
On day 4, the CR1aa control culture medium to be used for the next 4 days of
culture was prepared the same as for the day 1 through day 4 culture period but with the

34

addition of 5% fetal bovine serum (FBS). Medium was filtered with a 0.2 µm Acrodisc®
sterile filter (PN 4612, Pall Corporation) and placed into a Falcon® 35 x 10 mm plastic
petri dish containing four 75 µl droplets that were covered with warmed (39°C) medical
grade mineral oil. Dishes were placed in an incubator at 39°C for 45 to 60 minutes to
allow proper temperature and CO2 equilibration.
Fresh and frozen-thawed GX2 medium was supplemented with 0.5 mM of
glucose for culture from day 4 to day 8 of the experiment (as called for by the commercial
company protocol). Both fresh and the frozen GX2 medium was aliquoted into 20 ml and
supplemented with 180 mg of glucose (G-6152), then filtered with a 0.2 µm Acrodisc®
sterile filter (PN 4612, Pall Corporation). Four 75 µl droplets, covered with warmed
(39°C) medical grade mineral oil, were made in a Falcon® 35 x 10 mm plastic petri
dish(s) for fresh commercial culture medium and frozen-thawed commercial culture
medium. The Falcon® 35 x 10 mm plastic petri dishes were then placed in an incubator
at 39°C for 45 to 60 minutes to allow proper temperature and CO2 equilibration.
Embryo Culture
Once zygotes were received and washed in appropriate culture medium, 15
zygotes were randomly placed in each appropriate 75 µl droplet contained in Falcon® 35
x 10 mm plastic petri dishes. Prior to this the zygotes were evaluated for 1-cell, 2-cell
and 2- to 8-cell embryos and the data were recorded. The culture dishes were gassed in
a humidified culture chamber for 4 minutes with 90% N2, 5% O2 and 5% CO2. The
humidified chambers containing all treatments were then placed in a 39°C incubator to
be cultured until day 4 of the experiment.
On day 4, FBS supplemented CR1aa control culture medium was equilibrated in a
39°C incubator. Once the medium was equilibrated, embryos were removed from day 1
through day 4 culture droplets and placed into day 4 through day 8 culture droplets.
Embryos were evaluated for morphology and development, and the number of 1-cell, 2to 8-cell and 8- to 16-cell stages were recorded. Those at the 1-cell stage were not
transferred to new culture medium droplets. The embryos (n=15) were then placed in
each 75 µl droplet covered with warmed (39°C) medical grade mineral oil and gassed for
4 minutes with 90% N2, 5% O2 and 5% CO2. Humidified chambers were then placed in a
39°C incubator and embryos were cultured until day 8 of the experiment.
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Fresh and frozen-thawed GX2 medium supplemented with glucose was
equilibrated in a 39°C incubator. Once medium was equilibrated embryos were
transferred from day 1 through day 4 culture droplets to corresponding day 4 through day
8 culture droplets. Embryos were evaluated for morphology and development and data
were recorded. Development was grouped by 1-cell, 2- to 8-cell and 8- to 16-cell stages
and the remaining 1-cell zygotes were removed from culture. The embryos (n=15) were
placed in each 75 µl culture droplet covered with warmed (39°C) medical grade mineral
oil and gassed in a humidified culture chamber for 4 minutes with 90% N2, 5% O2 and
5% CO2. Humidified chambers were then placed in a 39°C incubator to be cultured until
day 8 of the study.
At ~192 hours post-insemination embryos were evaluated for development and
morphological quality. A sample of the day-8 blastocysts (n=~15%) in each culture
treatment group were randomly selected, stained in propidium iodide (for trophoblast
cells) and Hoechst 33342 (for ICM cells) and fixed to determine the total cell numbers
per embryo. Embryos were evaluated and graded using the RED scores system as
described previously (Ryan et al., 1992). Development was grouped by early blastocysts,
expanded blastocysts, hatching blastocysts and hatched blastocysts.
Statistical Analysis
Variances in embryo development and overall morphology were statistically
analyzed using X2 procedure of SAS (SAS Institute, Inc., Cary, NC). RED scores values
were analyzed using the Proc Mixed procedure of SAS (SAS Institute, Inc.). Variances
in inner cell mass cells (ICM), trophoblasts cells and total cell counts per embryo
compared among treatments were analyzed using the ANOVA procedure of SAS (SAS
Institute, Inc.). A P<0.05 value was considered statistically significant in this study.
Descriptive statistics were analyzed using SigmaStat Statistical Software Version 2.0.

Results
CR1aa Control Culture Medium
Treatment A, the laboratory control culture medium, was replicated six times from
April 30th to July 9th each time consisting of the same protocol. The percentages of 8- to
16-cell IVF-derived bovine embryos that developed in CR1aa medium at day 4 of culture
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and blastocysts on day 8 of culture are shown in Figure 3.1a and Figure 3.1b,
respectively. A mean of 43.0% of the embryos developed to the 8- to 16-cell stage on
day 4 of in vitro culture, whereas, the blastocyst development on day 8 was 29.0%.
There was no significant difference found among any of the six replicates for
development of the 8- to 16-cell stage embryos and among the replicates at the
blastocyst stage (Table 3.1). An example of day-8 CR1aa embryo development is
shown in Figure 3.2.
Embryo development was statistically analyzed further by evaluating the variation
of early blastocysts (EB), expanded blastocysts (XB), hatched blastocysts (Hatched) and
hatching blastocysts (Hatching) of each replication (Figure 3.3). The percentages of day8 IVF-derived bovine embryos that developed to the early blastocyst (EB), expanded
blastocyst (XB) and hatching blastocyst (Hatching) stages in a control CR1aa culture
medium are shown in Figure 3.4. The mean number of embryos that reached the early
blastocyst stage of development was 41.0%, expanded blastocyst stage of development
was 35.0%, hatching blastocyst stage of development was 22.0% and hatched stage of
development was 2.0%.
When Replicate 1 was evaluated for further development, of the 30.0% total day-8
blastocysts, 33.3% of IVF-derived embryos cultured in control medium developed to
early blastocysts, 33.3% developed to expanded blastocysts, 22.2% developed to
hatching blastocysts and 11.0% developed to hatched blastocysts. When Replicate 2
was evaluated for further development, of the 43.3% total day-8 blastocysts, 61.5% of
these IVF-derived embryos cultured in control medium developed to early blastocysts,
31.0% developed to expanded blastocysts, 8.0% developed to hatching blastocysts and
0% developed to hatched blastocysts. When Replicate 3 was evaluated for further
development, of the 36.7% total day-8 blastocysts, 9.0% of IVF-derived embryos cultured
in control medium developed to early blastocysts, 64.0% developed to expanded
blastocysts, 27.3% developed to hatching blastocysts and 0% developed to hatched
blastocysts.
When Replicate 4 was evaluated for further development, of the 20.0% total day-8
blastocysts, 50.0% of IVF-derived embryos cultured in control medium developed to
early blastocysts, 16.7% developed to expanded blastocysts, 33.3% developed to
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Table 3.1. Percentage of IVF-derived bovine embryos that developed in weekly
replicates of CR1aa culture medium.

Replicates*

Embryo Stages
Day-4
Day-8
8- to 16-Cells (%)
Blastocysts (%)

1

43.3a

30.0a

2

60.0a

43.3a

3

50.0a

36.7a

4

40.0a

20.0a

5

30.0a

10.0a

6

36.7a

33.3a

Mean =

43.3

28.9

*Each replicate of 30 zygotes for a total of 180 zygotes per 6 replicates.
Values within columns that have different superscpripts are statistically different
at P<0.05.

a,b

40

Figure 3.2. Day-8 IVF-derived bovine blastocysts cultured in CR1aa control culture
medium (10X magnification).

Figure 3.3. Day-8 IVF-derived bovine expanded and hatching blastocysts cultured in
CR1aa control culture medium (10X magnification).
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hatching blastocysts and 0% developed to hatched blastocysts. When Replicate 5 was
evaluated for further development, out of the 10.0% total day-8 blastocysts, 33.3% of
IVF-derived embryos cultured in control medium developed to early blastocysts, 33.3%
developed to expanded blastocysts, 33.3% developed to hatching blastocysts and 0%
developed to hatched blastocysts. When Replicate 6 was evaluated for further
development, out of the 33.3% total day-8 blastocysts, 60.0% of IVF-derived embryos
cultured in control medium developed to early blastocysts, 30.0% developed to
expanded blastocysts, 10.0% developed to hatching blastocysts and 0% developed to
hatched blastocysts. There was no significant difference found among any of the six
replicates within the same developmental stage. However, the validity of the test
performed on the hatched blastocyst group is questionable due to the low number of
embryos that reached this developmental stage.
GX2 Commercial Culture Medium
The percent cleavage (day 4) of 2- to 8-cell IVF-derived bovine embryos that
developed during in vitro culture in fresh or frozen-thawed commercial culture medium is
shown in Figure 3.5. The 1-cell zygotes that did not develop were discarded at this point
of the culture period. When evaluated on day 4 for cleavage, Treatment B (Fresh 0
weeks) had 11.2% 1-cell embryos and 37.2% 2- to 8-cell embryos. Storage time period
for Frozen 3 days was evaluated on day 4 for cleavage and recorded 14.3% 1-cell
embryos and 37.7% 2- to 8-cell embryos. When storage time period for Frozen 2 weeks
was evaluated cleavage was recorded as 11.7% 1-cell embryos and 34.3% 2- to 8-cell
embryos. When storage time period for Frozen 4 weeks was evaluated cleavage was
recorded as 14.0% 1-cell embryos and 40.3% 2- to 8-cell embryos. Storage time period
for Frozen 6 weeks was evaluated on day 4 and cleavage was recorded as 10.0% 1-cell
embryos and 46.0% 2- to 8-cell embryos. When storage time period for Frozen 8 weeks
was evaluated cleavage was recorded as 16.7% 1-cell embryos and 42.0% 2- to 8-cell
embryos. Finally, storage time period for Frozen 10 weeks was evaluated on day 4 and
cleavage was 19.0% 1-cell embryos and 40.7% 2- to 8-cell embryos. There was no
statistical difference in 2- to 8-cell embryo cleavage when comparing Fresh 0 weeks with
any of the different storage period times of frozen commercial culture medium (Frozen 3
day, Frozen 2 weeks, Frozen 4 weeks, Frozen 6 weeks, Frozen 8 weeks and Frozen 10
weeks).
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Development of 8- to 16-Cell Embryos in Culture
The percentage of 8- to 16-cell IVF-derived bovine embryos that developed during
in vitro culture in fresh or frozen-thawed commercial culture medium is shown in Figure
3.6 and Table 3.2. In the commercial culture medium development was assessed on
day 4 at the 8- to 16-cell stage for both Treatment B and Treatment C. When Treatment
B, which contained six replicates of one storage time period (Fresh 0 weeks), was
evaluated, the percentage of 8- to 16-cell IVF-derived embryos that developed in fresh
commercial culture medium was 51.7%.
Treatment C contained six different storage time periods with various frozen
treatments repeated three times in each of the six replicates performed. When the first
storage time period of Treatment C, Frozen 3 days, was evaluated, the percentage of 8to 16-cell IVF-derived embryos that developed in frozen-thawed commercial culture
medium was 47.8%. The next storage treatment time evaluated, Frozen 2 weeks,
showed that the percentage of 8- to 16-cell IVF-derived embryos that developed in
frozen-thawed commercial culture medium was 53.8%. When storage time period for
Frozen 4 weeks was evaluated, the percentage of 8- to 16-cell IVF-derived embryos that
developed in frozen-thawed commercial culture medium was 45.4%.
When storage time period for Frozen 6 weeks was evaluated, the percentage of
8- to 16-cell IVF-derived embryos that developed in frozen-thawed commercial culture
medium was 44.1%. When storage time period for Frozen 8 weeks was evaluated, the
percentage of 8- to 16-cell IVF-derived embryos that developed in frozen-thawed
commercial culture medium was 41.2%. When the final storage time period, Frozen 10
weeks, was evaluated, the percentage of 8- to 16-cell IVF-derived embryos that
developed in frozen-thawed commercial culture medium was 40.4%.
There was no significant difference found between Treatment B (Fresh 0 weeks)
when compared with storage time periods for Frozen 3 days, Frozen 2 weeks, Frozen 4
weeks, and Frozen 6 weeks. However, when Treatment B (Fresh 0 weeks) was
compared with Frozen 8 weeks and then again with Frozen 10 weeks there was a
significant difference (P<0.05) in development found between the Fresh and Frozen
treatments of both groups. There was also a significant difference (P<0.05) in
development found between storage times for Frozen 2 weeks versus Frozen 6 weeks,
Frozen 8 weeks and Frozen 10 weeks and Frozen 4 versus Frozen 10 weeks.
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Table 3.2. Percentage (±SE) of 8- to 16-cell IVF-derived bovine embryos that
developed in fresh or frozen-thawed GX2 commercial culture medium.

Medium Storage Time

a,b

8- to 16-Cells (%)

Fresh 0 weeks

51.7 ± 3a

Frozen 3 days

47.8 ± 9ab

Frozen 2 weeks

53.8 ± 5ab

Frozen 4 weeks

45.4 ± 9ab

Frozen 6 weeks

44.1 ± 7ab

Frozen 8 weeks

41.2 ± 11b

Frozen 10 weeks

40.4 ± 6b

Values with different superscripts are statistically different at P<0.05.

.
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Blastocyst Development in Culture
The percentage of IVF-derived bovine embryos that developed into blastocysts
during in vitro culture in fresh or frozen-thawed commercial culture medium is shown in
Figure 3.7 and Table 3.3. In the commercial culture medium, development was
assessed on day 8 at the blastocyst stage for both Treatment B and Treatment C (Figure
3.8). When Treatment B, which contained six replicates of the control storage time
period (Fresh 0 weeks), was evaluated, the percentage of IVF-derived blastocysts that
developed in fresh commercial culture medium was 28.4%. Treatment C contained six
different storage time periods with various frozen treatments repeated three times in
each of the six replicates performed. When the first storage time period of Treatment C,
Frozen 3 days, was evaluated the percentage of IVF-derived blastocysts that developed
in frozen-thawed commercial culture medium was 31.1%. The next storage treatment
time evaluated, Frozen 2 weeks, found the percentage of IVF-derived blastocysts that
developed in frozen-thawed commercial culture medium was 29.5%.
When storage time period for Frozen 4 weeks was evaluated, the percentage of
IVF-derived blastocysts that developed in frozen-thawed commercial culture medium
was 27.3%. When storage time period for Frozen 6 weeks was evaluated, the
percentage of IVF-derived blastocysts that developed in frozen-thawed commercial
culture medium was 26.4%. When storage time period for Frozen 8 weeks was
evaluated, the percentage of IVF-derived blastocysts that developed in frozen-thawed
commercial culture medium was 23.3%. When the final storage time period, Frozen 10
weeks, was evaluated, the percentage of IVF-derived blastocysts that developed in
frozen-thawed commercial culture medium was 24.8%. There was no significant
difference found between Treatment B (Fresh 0 weeks) and all the different storage time
periods of Treatment C (Frozen 3 days, Frozen 2 weeks, Frozen 4 weeks, Frozen 6
weeks, Frozen 8 weeks and Frozen 10 weeks).
Embryo development was statistically analyzed further by evaluating the variation
of early blastocysts, expanded blastocysts, hatched blastocysts and hatching blastocysts
of each treatment group. The percentage of day-8 IVF-derived bovine blastocysts that
developed to the early blastocyst, expanded blastocyst and hatching blastocyst stage in

48

80

n=1,914
70

Blastocyst Stage (%)

60

50

40

30

20

10

0
Fresh
0 weeks

Frozen
3 days

Frozen
2 weeks

Frozen
4 weeks

Frozen
6 weeks

Frozen
8 weeks

Frozen
10 weeks

Medium Storage Time
Figure 3.7. Percentage of IVF-derived bovine embryos that developed into
blastocysts on day 8 of in vitro culture in fresh or frozen-thawed commercial
th
th
culture medium beginning on April 30 and ending on July 9 .

49

Table 3.3. Percentage (±SE) of IVF-derived bovine blastocysts that developed
in fresh or frozen-thawed GX2 commercial culture medium.

Medium Storage Time

Blastocysts (%)

Fresh 0 weeks

28.4 ± 4a

Frozen 3 days

31.1 ± 7a

Frozen 2 weeks

29.5 ± 4a

Frozen 4 weeks

27.3 ± 4a

Frozen 6 weeks

26.4 ± 2a

Frozen 8 weeks

23.3 ± 5a

Frozen 10 weeks

24.8 ± 3a

a,b

Values with different superscripts are statistically different at P<0.05.
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Figure 3.8. Day-8 IVF-derived bovine blastocysts cultured in fresh GX2 commercial
culture medium (10X magnification).
fresh or frozen-thawed commercial culture medium is shown in Figure 3.9. An example
of further embryo development in GX2 medium is shown in Figure 3.10 and Figure 3.11.
When Treatment B (Fresh 0 weeks) was evaluated for further development, of the 28.4%
total blastocysts, 66.7% of IVF-derived embryos cultured in fresh commercial culture
medium developed to early blastocysts, 33.3% developed to expanded blastocysts, 0%
developed to hatching blastocysts and 0% developed to hatched blastocysts.
When the first storage time period of Treatment C, Frozen 3 days, was evaluated
for further development, of the 31.1% total blastocysts, 75.0% of IVF-derived embryos
cultured in frozen-thawed commercial culture medium developed to early
blastocysts,17.9% developed to expanded blastocysts, 4.0% developed to hatching
blastocysts and 4.0% developed to hatched blastocysts. When storage time period for
Frozen 2 weeks was evaluated for further development, of the 29.5% total blastocysts,
64.0% of IVF-derived embryos cultured in frozen-thawed commercial culture medium
developed to early blastocysts, 33.0% developed to expanded blastocysts, 3.0%
developed to hatching blastocysts and 0% developed to hatched blastocysts. When
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Figure 3.10. Day-8 IVF-derived bovine expanded blastocyst cultured in frozen-thawed
GX2 commercial culture medium (20X magnification).

Figure 3.11. Day-8 IVF-derived bovine blastocysts cultured in frozen-thawed GX2
commercial culture medium (10X magnification).
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storage time period for Frozen 4 weeks was evaluated for further development, of the
27.3% total blastocysts, 71.0% of IVF-derived embryos cultured in frozen-thawed
commercial culture medium developed to early blastocysts, 28.0% developed to
expanded blastocysts, 1.0% developed to hatching blastocysts and 0% developed to
hatched blastocysts. When storage time period for Frozen 6 weeks was evaluated for
further development, of the 26.4% total blastocysts, 67.0% of IVF-derived embryos
cultured in frozen-thawed commercial culture medium developed to early blastocysts,
33.0% developed to expanded blastocysts, 0% developed to hatching blastocysts and
0% developed to hatched blastocysts.
When storage time period for Frozen 8 weeks was evaluated for further
development, of the 23.3% total blastocysts, 75.0% of IVF-derived embryos cultured in
frozen-thawed commercial culture medium developed to early blastocysts, 25.0%
developed to expanded blastocysts, 0% developed to hatching blastocysts and 0%
developed to hatched blastocysts. When the final storage time period, Frozen 10 weeks,
was evaluated for further development, of the 24.8% total blastocysts, 69.0% of IVFderived embryos cultured in frozen-thawed commercial culture medium developed to
early blastocysts, 28.0% developed to expanded blastocysts, 2.0% developed to
hatching blastocysts and 1.0% developed to hatched blastocysts. There was no
significant difference found between Treatment B (Fresh 0 weeks) and any of the
different storage times of Treatment C (Frozen 3 days, Frozen 2 weeks, Frozen 4 weeks,
Frozen 6 weeks, Frozen 8 weeks and Frozen 10 weeks) when evaluating the same
developmental stage.
The mean RED scores for IVF-derived bovine embryos recorded on day 8
following in vitro culture in fresh or frozen-thawed commercial culture is shown in Figure
3.12 and Table 3.4. In the commercial culture medium, morphology on day 8 was
assessed as well as development for both Treatment B and Treatment C. A RED score
was assigned to each embryo based on morphology and stage of development. When
Treatment B, which contained six replicates of one storage time period (Fresh 0 weeks),
was evaluated, the mean value assigned to the early blastocysts of IVF-derived embryos
that developed in fresh commercial culture medium was 1.70% and the mean value
assigned to expanded blastocysts was 2.85%. An example of further embryo
development to day 9 is shown in Figure 3.13.
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Table 3.4. Mean RED scores (±SEM) recorded on day 8 following bovine embryo culture in fresh or
frozen-thawed GX2 commercial culture medium.

Embryos*
Medium Storage Time

Early Blastocysts

Expanded Blastocysts

Fresh 0 weeks

1.70 ±0.01a

2.85 ±0.06a

Frozen 3 days

1.72 ±0.06a

2.89 ±0.11a

Frozen 2 weeks

1.69 ±0.05a

2.89 ±0.04a

Frozen 4 weeks

1.76 ±0.07a

2.95 ±0.03a

Frozen 6 weeks

1.74 ±0.01a

2.86 ±0.02a

Frozen 8 weeks

1.52 ±0.12a

2.82 ±0.04a

Frozen 10 weeks

1.70 ±0.02a

2.88 ±0.04a

a,b

Mean values within columns that have different superscpripts are statistically different at P<0.05.
*Embryos were evaluated on day 8 of culture.
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Figure 3.13. Day-9 IVF-derived bovine hatched blastocysts cultured in fresh GX2
commercial culture medium (10X magnification).
Treatment C contained six different storage time periods with various frozen
treatments repeated three times in each of the six replicates performed. When the first
storage time period of Treatment C, Frozen 3 days, was evaluated, the mean value
assigned to the early blastocysts of IVF-derived embryos that developed in frozenthawed commercial culture medium was 1.72% and mean the value assigned to
expanded blastocysts was 2.89%. When storage time period for Frozen 2 weeks was
evaluated, the mean value assigned to the early blastocysts of IVF-derived embryos that
developed in frozen-thawed commercial culture medium was 1.69% and the mean value
assigned to expanded blastocysts was 2.89%. When storage time period for Frozen 4
weeks was evaluated, the mean value assigned to the early blastocysts of IVF-derived
embryos that developed in frozen-thawed commercial culture medium was 1.76% and
the mean value assigned to expanded blastocysts was 2.95%.
When storage time period for Frozen 6 weeks was evaluated, the mean value
assigned to the early blastocysts of IVF-derived embryos that developed in frozenthawed commercial culture medium was 1.74% and the mean value assigned to
expanded blastocysts was 2.86%. When storage time period for Frozen 8 weeks was
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evaluated, the mean value assigned to the early blastocysts of IVF-derived embryos that
developed in frozen-thawed commercial culture medium was 1.52% and the mean value
assigned to expanded blastocysts was 2.82%. When the final storage time period,
Frozen 10 weeks, was evaluated, the mean value assigned to the early blastocysts of
IVF-derived embryos that developed in frozen-thawed commercial culture medium was
1.70% and the mean value assigned to expanded blastocysts was 2.88%. There was no
significant difference among early blastocysts or among expanded blastocysts analyzed
between Treatment B (Fresh 0 weeks) and any of the different frozen storage time
periods of Treatment C (Frozen 3 days, Frozen 2 weeks, Frozen 4 weeks, Frozen 6
weeks, Frozen 8 weeks and Frozen 10 weeks).
The percent mean inner cell mass (ICM) and percent mean trophoblast cell
counts from day-8 IVF-derived bovine embryos cultured in fresh or frozen-thawed
commercial culture medium is shown in Table 3.5. After morphology and development
were recorded a sample of the day-8 blastocysts (n=~15) in each culture treatment group
were randomly selected, stained in propidium iodide (for trophoblast cells) and Hoechst
33342 (for ICM cells) and fixed to determine the total cell numbers per embryo (Figure
3.14 and Figure 3.15). When evaluated, Treatment B (Fresh 0 weeks) recorded a final
count of 45.4 ICM cells and 85.1 trophoblast cells. Storage time period for Frozen 3
days resulted in a final count of 39.0 ICM cells and 79.3 trophoblast cells. When storage
time period for Frozen 2 weeks was evaluated, a final count of 45.3 ICM cells and 79.2
trophoblast cells were recorded.
Storage time period for Frozen 4 weeks resulted in a final count of 50.5 ICM cells
and 75.4 trophoblast cells. When evaluated, storage time period for Frozen 6 weeks
recorded a final count of 49.4 ICM cells and 86.2 trophoblast cells. When storage time
period for Frozen 8 weeks was evaluated, a final count of 49.1 ICM cells and 90.1
trophoblast cells were recorded. Lastly, storage time period for Frozen 10 weeks
resulted in a final count of 36.5 ICM cells and 90.6 trophoblast cells. There was no
significant difference found between Treatment B (Fresh 0 weeks) and any of the storage
time periods of Treatment C (Frozen 3 days, Frozen 2 weeks, Frozen 4 weeks, Frozen 6
weeks, Frozen 8 weeks and Frozen 10 weeks) for neither ICM cell count nor trophoblast
cell count.
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Table 3.5. Percent mean inner cell mass (±SEM) and percent mean trophoblast cell counts (±SEM) from day8 IVF-derived bovine embryos cultured in fresh or frozen-thawed GX2 commercial medium.

ICM

Trophoblasts

Total Cells

Fresh 0 weeks

45.4 ± 5.1a

85.1 ±11.4a

130.5a

Frozen 3 days

39.0 ±19.5a

79.3 ±14.7a

118.3a

Frozen 2 weeks

45.3 ±0.3a

79.2 ±8.4a

124.5a

Frozen 4 weeks

50.5 ±13.2a

75.4 ±11.2a

125.9a

Frozen 6 weeks

49.4 ±2.7a

86.2 ±3.4a

135.6a

Frozen 8 weeks

49.1 ±2.7a

90.1 ±7.2a

139.2a

Frozen 10 weeks

36.5 ±9.4a

90.6 ±9.9a

127.0a

Medium Storage Time

a,b

Values within columns with different superscipts are statistically different at P<0.05.
ICM=Inner cell mass.
15% of embryos were selected from each treatment group.
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Figure 3.14. Day-8 IVF-derived bovine blastocyst cultured in fresh GX2 commercial
culture medium stained with propidium iodide (for trophoblast cells) and Hoechst 33342
(for ICM cells) (10X magnification).

Figure 3.15. Day-8 IVF-derived bovine blastocyst cultured in frozen-thawed GX2
commercial culture medium stained with propidium iodide (for trophoblast cells) and
Hoechst 33342 (for ICM cells) (10X magnification).
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Discussion
Storage of embryo culture media for up to 2 weeks is currently the maximum
amount recommended by Purdy (1982) and Quinn et al. (1984) and part of the guidelines
of the American Fertility Society (AFS) for ART programs (Gerrity et al., 1992). AFS and
the College of American Pathologists (CAP) partnered to form an accreditation program
ensuring high quality control standards, such as limited media storage time (McLendon,
1992). However, others propose that the media can be refrigerator stored or frozenstored for longer periods of time for use in human embryo culture (Naz et al., 1986;
Bernart et al., 1990; De Silva, 1993; Bell et al., 1995).
The use of frozen-thawed media would enable more efficient use of a single batch
of medium and thus, more consistent data may be gained from the same batch of culture
medium. Costs can be lowered per cycle because a number of different IVF cycles can
be produced within the same batch of medium. To discard medium that supports in vitro
fertilization and early embryo development merely to adhere to arbitrary guidelines
regarding storage limitations is wasteful (Bell et al., 1995). Furthermore, inordinately
frequent preparation of medium is inefficient use of personnel and materials (Bell et al.,
1995).
In this experiment, a control bovine IVF culture medium (CR1aa) was used to
monitor our in vitro development system, which previously had consistent results in the
production of bovine embryos in our laboratory. In a study by Rosenkrans and First
(1994), the developmental rates of morula and blastocyst stage embryos are similar or
slightly decreased to our developmental rates when the CR1aa stock medium was
refrigerator stored at 4°C up to 3 months. In our study replicates were performed
simultaneously with the fresh and frozen-thawed IVF procedures to monitor the process
and quality control. No significant difference was found in the development of 8- to 16cell stage and blastocyst stage embryos among the six replicates performed with the
control CR1aa medium. When development to the early blastocyst, expanded blastocyst
and hatching blastocyst stage was evaluated further there was no difference in any of the
three developmental stages found when compared among replicates. The number of
embryos that reached the hatched blastocyst stage, however, was likely not sufficient for
a valid statistical test.
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In this experiment, cleavage was divided into two groups and recorded as the
number of 2- to 8-cell embryos on day 4 and the number of 8- to 16-cells recorded on
day 4. When evaluating cleavage of fresh versus frozen-thawed medium there was no
developmental difference found among embryos at the 2- to 8-cell stage.
We did find, however, the freezing of a human IVF commercial culture medium at
-20°C resulted in a significant decrease of bovine 8- to 16-cell development on day 4
when the medium was frozen for 8 weeks as well as frozen for 10 weeks when
compared with fresh commercial culture medium. There was no significant decrease in
development of the 8- to 16-cell stage when compared with the control Fresh 0 weeks
when commercial culture medium was frozen for 3 days, 2 weeks, 4 weeks or 6 weeks.
In storage period time for Frozen 2 weeks, 8- to 16-cell stage embryo development was
actually slightly increased than that of the fresh control at 0 weeks. The 8- to 16-cell
stage has been reported as the in vitro developmental block in bovine embryos (Thibault,
1966; Brackett et al., 1982; Camous et al., 1984; First and Parrish, 1987; Aoyagi et al.,
1990; Keskintepe et al., 1995). This point in embryo cell division is known as the
maternal to zygotic transition and may be very susceptible to components in culture
media. Keskintepe et al. (1995) indicated one of the factors attributed to bovine
embryonic development is the transfer of embryotrophic factors or metabolism from the
culture media. Eyestone and First (1989), as well as Gandolfi and Moor (1987) agree
that specific energy substrates may be necessary or detrimental for development of
bovine embryos at this stage. Kim et al. (1993) reported that bovine oocytes matured
and fertilized in a defined, protein free medium developed to the blastocyst stage with
almost the same efficiency that has been obtained in co-culture, however it is essential to
include amino acids, phosphate, pyruvate and lactate in the medium and glucose is
necessary for later stages of development.
The energy requirements of bovine embryos during cleavage stages have not
been fully defined (Rexroad, 1989; Rieger, 1992), in part, because of the difficulty
imposed by the 8- to 16-cell in vitro developmental block (Thibault, 1966; Brackett et al.,
1982; Camous et al., 1984; First and Parrish, 1987; Aoyagi et al., 1990; Keskintepe et
al., 1995). The coincidence of this environmentally induced phenomenon with the
maternal to zygotic transition is a point of considerable discussion (Bavister, 1988;
Crosby et al., 1988; First and Barnes, 1989).
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In the present experiment, 8- to 16-cell development was evaluated before the
commercial culture medium was supplemented with glucose, which may account for the
delayed or declined development due to the lack of this energy substrate in the medium.
There are varying opinions on the addition of glucose to bovine embryo culture media.
Rosenkrans et al. (1993) and Takahashi and First (1992) reported that glucose may not
be the best choice of energy substrate because bovine embryo development decreased
or was inhibited when glucose was added to the culture media. Takahashi and First
(1992) indicated that glucose is not only unnecessary but at 5.56 mM it causes
detrimental effects on bovine embryonic development to the morula stage. In contrast,
Wirtu et al. (2004) reported beneficial results when glucose was supplemented through
the entire culture period of bovine embryos. In agreement, Pantaleon et al. (2001) and
Comizzoli et al. (2003) indicated that although the mechanism by which glucose exerts
its effects during embryo development is not fully elucidated, its effects are evident as
early as the fertilization stage in mice and bovine.
Therefore, in the present study, it is unknown if 8- to 16-cell development was
significantly decreased in medium frozen (-20°C) for 8 to 10 weeks because of the
detrimental effects of the post-thaw medium or because of the different requirements
needed by bovine embryos not provided by the human commercial culture medium.
In this study, there were no significant differences in bovine blastocyst
development among any of the different storage time periods of the fresh and frozenthawed commercial culture medium previously stored at -20°C. These results are in
agreement with those reported for the frozen storage of Ham’s F-10 medium used for
murine and human in vitro fertilization by Bernart et al. (1990). Initially, they found there
was no significant difference in development of mouse embryos to the expanded and
hatched blastocyst stage cultured in Ham’s F-10 medium frozen at -20°C for up to 6
months. Following the animal results, the frozen-thawed medium was applied to human
IVF and the results were the same, there was no loss of quality of the frozen-stored
Ham’s F-10 medium within the 3 month test period.
When looking at storage time periods Frozen 3 days and Frozen 2 weeks (as with
8- to 16-cell development) there was a pattern for bovine blastocyst development on day
8 to be increased over that of the control (Fresh 0 weeks) but these developmental rates
were not significant from the control fresh medium. Bernart et al. (1990) also suggested

63

that there was a pattern for higher fertilization and pregnancy rates of the human IVF
embryos cultured in the frozen-stored Ham’s F-10 medium when compared with the
nonfrozen medium but this was not significant.
We evaluated development further to the early blastocyst and expanded
blastocyst stages and found there was no difference in either developmental stage when
compared among the treatment groups. The number of embryos that reached the
hatching blastocyst stage and hatched blastocyst stage was likely not sufficient for a
valid statistical test. Bernart et al. (1990) reported similar results in murine embryos
cultured in frozen-thawed Ham’s F-10 medium, there was no significant difference in the
rates of expanded and hatched blastocysts between the subgroups cultured in fresh or
frozen (-20°C) medium stored for up to 6 months.
When evaluating RED scores of early blastocysts in the present study, no
significant differences were found in the grades of IVF-derived bovine embryos among
fresh medium and any of the frozen-thawed storage period times. There was also no
significant difference in RED scores value among expanded blastocysts when evaluating
fresh and any of the frozen-thawed storage period times. In contrast to our results, Ryan
et al. (1992) reported a significant amount of variation in RED scores when heat stressed
embryos were cultured in different heat stress treatments for different time periods.
When the cell counts of day-8 IVF-derived bovine embryos were evaluated there
was no significant difference found when cultured in either the fresh or the frozen-thawed
commercial culture medium. However, again there was a pattern for total cell count to
be equal to or increased in storage time periods for Frozen 6 weeks, Frozen 8 weeks
and Frozen 10 weeks. Although there was an increased pattern there was no significant
difference in development between these frozen storage time periods and the fresh
commercial culture medium.
These results indicate that freezing human commercial culture medium at -20°C
results in decreased 8- to 16-cell development when embryos are cultured in medium
that has been frozen for 8 to 10 weeks. This is problematic because the norm for most
human fertility clinics has been to transfer embryos on day 3 or day 4 known as the
“cleaving embryo” stage. Edwards et al. (1980) and Steptoe et al. (1980) pioneered the
human IVF procedure by transferring embryos at the cleavage stage into the
synchronized uterus of the human female. Research is now being done to extend the
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human embryo culture period out to day 5 or day 6 for transfer in an effort to select for
embryo viability (Barnes et al., 1995; Gardner et al., 1998; Jones and Trounson, 1999;
Cruz et al., 1999; Behr et al., 1999; Schoolcraft et al., 1999; Milki et al., 2000; Gardner et
al., 2000; Alper et al., 2001). Alper et al. (2001) proposed that the culture of human
embryos to the blastocyst stage of development has been advocated to increase the
efficiency of IVF by improving embryo selection for increased implantation potential,
reducing the number of embryos transferred and lowering the incidence of multiple
gestations. Although there may be future advantages, a large amount of the data
available to date is limited primarily to patients with good prognosis (Gardner et al., 1998;
Schoolcraft et al., 1999).
To our knowledge this study was the first to evaluate bovine embryos in a frozenthawed human commercial culture medium. Due to the commercial company protocol
glucose was supplemented on day 4; however, there is much controversy over the
addition of glucose when culturing bovine embryos in vitro. In a previous study,
conducted at our university, Wirtu et al. (2004) demonstrated that bovine embryos
cultured in modified KSOM (mKSOM-20aa, which includes 0.2 mM of glucose) with the
addition of 20 amino acids achieved normal blastocyst development rates (42%). The
commercial culture medium used in the present study was very similar in composition to
modified KSOM (Lawitts and Biggers, 1991b) with the addition of amino acids; however,
in the present study the concentration of glucose supplemented to the commercial
culture medium was 0.5 mM. Wirtu (2004) reported low frequency of day-7 blastocysts
indicating slow embryonic development in mKSOM-20aa but the frequency increased
and by day 9 of culture development reached 42%. These data are similar to our results
indicating decreased or delayed embryonic development at the 8- to 16-cell stage of
embryos cultured in commercial medium frozen at -20°C for 8 to 10 weeks. The slow
development indicates reduced developmental competence as reported for bovine and
other species (Massip et al., 1995; Bavister, 2002). Further research must be performed
on human commercial culture medium to determine if there is a delay around the 8- to
16-cell stage due to bovine embryo development in an alternate culture medium or if
there is a composition change in the frozen-thawed culture medium.
Since this experiment showed no decreased development in blastocysts at day 8
among any of the treatments, we can assume that GX2 commercial culture medium can
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be frozen at -20°C for up to 10 weeks and used without any detrimental effects to
development of day-8 bovine blastocysts. However, human embryos are not usually
cultured to day 8 before transfer, but with ongoing research of human blastocyst transfer
(Barnes et al., 1995; Gardner et al., 1998; Jones and Trounson, 1999; Cruz et al., 1999;
Behr et al., 1999; Schoolcraft et al., 1999; Milki et al., 2000; Gardner et al., 2000; Alper et
al., 2001) this information may be important when considering cleavage stage transfer
versus blastocyst stage transfer. Further research is needed to evaluate the rate of
development in this frozen-thawed medium to determine if there is composition change
of the culture medium.
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CHAPTER IV
EXPERIMENT II
IN VITRO DEVELOPMENT OF BOVINE EMBRYOS USING FROZEN-THAWED
COMMERCIAL CULTURE MEDIUM CRYOPRESERVED AT -80°C
Introduction
Over the years technology has advanced in treating infertile couples, with in vitro
fertilization (IVF) and embryo transfer (ET) becoming two of the most important
methodologies. De Silva (1993) indicated that one of the most critical issues when
setting up an IVF laboratory is how gametes and embryos are going to be maintained in
the laboratory prior to patient transfer. Thus, laboratories must have the best available
embryo culture system in place to maintain quality control. At the present time, it is
recommended that culture media for embryo culture should be stored for no longer than
1 to 2 weeks at 4°C (Purdy, 1982; Quinn et al., 1984; Gerrity et al., 1992; McLendon,
1992). Preparing new media every 2 weeks is time consuming and expensive resulting
in decreased efficiency for the laboratory. Naz et al. (1986) showed that storing Ham’s
F-10 medium for up to 425 days at 4°C did not affect 2-cell mouse embryo development
to blastocysts in culture. However, Silverman et al. (1987) and Davidson et al. (1988a)
indicated that the 2-cell mouse embryo may not be sensitive to subtle changes in the
culture medium used for human embryos and, therefore, may not have detected any
differences between the freshly prepared and the stored culture media. In another study,
Bernart et al. (1990) reported that Ham’s F-10 medium could be frozen without affecting
2-cell mouse embryo development in vitro or affecting pregnancy rates in women
undergoing IVF. In this study, it should be noted that the sodium bicarbonate solution
and Ham’s F-10 medium were frozen separately and mixed prior to use, adjusting for
osmolarity if needed.
De Silva (1993) stated that it would be ideal if a culture medium, once prepared,
could be simply stored at 4°C and used for embryo cultures without compromising the
development of the embryo. An experiment was designed where 1-cell mouse embryos
were cultured in Ham’s F-10 medium freshly prepared (Fresh) or stored up to 6 months
in a refrigerator at 4°C (Stored), to determine if storing the medium at 4°C affects embryo
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development in vitro. The results showed no significant difference in murine embryo
development to early, expanded, hatched and hatching stages, whether embryos were
cultured in the fresh or the stored medium. De Silva (1993) proposed that these findings
indicated that Ham’s F-10 medium can be stored in a refrigerator at 4°C for up to 6
months without compromising 1-cell mouse embryo development in vitro. The results of
this study are in agreement with those of Naz et al. (1986) and the two previous studies
reported by Bernart et al. (1990) showing that Ham’s F-10 medium can be stored
refrigerated (4°C) or frozen (-20°C) without affecting 2-cell mouse embryo development
in vitro.
Freezing IVF culture media creates advantages that are not available with the
recommended storage time of 1 to 2 weeks. The prolonged storage time allows for
multiple tests and cross tests to be performed on a single batch of medium. One
problem that arises with limited storage time of culture media is the inability to perform all
the assays needed. The average time to perform an assay on a batch of culture medium
is usually 4 to 5 days leaving only 1 week of usable time left to use the culture medium.
Another quality control method is to compare results among human infertility clinics,
however, when one batch is being used for only 2 weeks little data are generated for
comparisons. The ability to freeze culture media increases the number of IVF cycles that
can be performed with the same medium producing more data that could be analyzed.
Bernart et al. (1990) described a method for frozen storage of Ham’s F-10
medium that is very simple, easy to use and provides ‘ready-to-use’ medium (within a
few minutes) for IVF at any time. The results of freezing Ham’s F-10 medium at -20°C
and then thawing showed that there is no loss of quality for at least several months in the
mouse embryo model and possibly the clinical experience in human IVF. Bernart et al.
(1990) pointed out this prolonged period of availability of one single medium preparation
offers the possibility of being able to make extensive quality tests in an animal model for
a new medium preparation before using it in human IVF. Bell et al. (1995) indicated, that
there was no data reported in the literature suggesting a specific time point at which
Ham’s F-10 medium, used worldwide in human IVF programs, was no longer supportive
for human pre-implantation embryos. Their results suggested that Ham’s F-10 medium
could be stored at 4°C for at least 3 months and still provide adequate support for
fertilization and early in vitro development of the 4-cell stage human embryo.
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The objective of this study was to test fresh and frozen-thawed commercial
culture medium at -80°C by evaluating IVF-derived bovine embryo development and
quality.

Materials and Methods
Experimental Design
The experimental design originated from the commercial media company. This
experiment was conducted to determine the developmental potential of IVF-derived
bovine embryos cultured in a commercial medium frozen and stored at -80°C for 1 month
and then stored at 4°C for various time periods for use in embryo culture. IVF-derived
bovine blastocysts cultured in frozen commercial medium were then compared with IVFderived bovine blastocysts cultured in the same fresh commercial medium. For this
experiment bovine 1-cell zygotes were shipped by FedEx Priority Overnight to the
Louisiana State University Agricultural Center Embryo Biotechnology Laboratory from a
commercial source in a portable incubator. The zygotes were shipped in the afternoon
and arrived between 10 am and 12 pm the next day.
There were three treatment groups in this experiment, Treatment A was a
laboratory control CR1aa culture medium, Treatment B was a fresh commercial culture
medium that was stored at 4°C for various time periods and Treatment C was a frozenthawed commercial culture medium. Treatment A (n=12 replicates) contained a total of
1,124 zygotes and was replicated 12 times from January 13th to May 5th each time
consisting of the exact same protocol. Treatment B (n=12 replicates, one or two
treatments per replicate) with a total of 1,500 zygotes and Treatment C (n=11 replicates)
with a total of 1,102 zygotes. For this experiment Treatment B was divided into three
different storage time periods; Fresh 0 weeks, Fresh 1 week and Fresh 2 weeks.
Treatment C was also divided into three different storage time periods; Frozen 0 weeks,
Frozen 1 week and Frozen 2 weeks. Frozen medium had been previously frozen and
stored for 1 month at -80°C then shipped on dry ice to our laboratory within 1 day, 1
week, or 2 weeks of its use. Over a period of 4 months 12 trials were performed, each
one including a group of IVF-derived embryos cultured in media from Treatment A and
Treatment C and a group(s) of embryos cultured in Treatment B (Appendix E).
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Zygotes in each replicate were randomly assigned to each of the three treatment
groups and were cultured in appropriate culture media from day 1 through day 4. CR1aa
culture medium in Treatment A was supplemented with 5% fetal bovine serum (FBS) on
day 4 and cultured until day 8 of the experiment. On day 4 the commercial culture
medium in Treatments B and C was supplemented with 0.5 mM of glucose (G-6152,
Sigma-Aldrich, Inc., St. Louis, MO) and cultured from day 4 to day 8 of the experiment.
Cleavage and blastocyst rates were assessed on day 4 and day 8 of in vitro culture,
respectively, for all treatment groups.
Experimental Procedure
The name of the commercial culture medium used in this experiment can not be
disclosed for proprietary reasons, so for this thesis we have assigned a code name of
GX2. The fresh and frozen GX2 medium arrived on ice (wet and dry, respectively) from
the commercial media company by FedEx at the Louisiana State University Embryo
Biotechnology Laboratory (EBL) and was stored at 4°C according to its allotted time
period. Frozen medium had been previously frozen and stored for 1 month at -80°C then
shipped on dry ice to our laboratory within 1 day, 1 week or 2 weeks of its use. The fresh
medium was shipped on wet ice to our laboratory within 1 day, 1 week or 2 weeks of its
use. The day of use frozen medium was removed from 4°C storage, where it had been
placed after arrival. When removed from storage if frozen medium was partially thawed
to complete the thawing process it was placed into a 37°C water bath.
Zygote Receipt and Preparation for Culture
Bovine zygotes were received in a portable incubator (Minitube®, Minitube
America) at 39°C from a commercial supplier (BOMED, Inc., Madison, WI) (Figure 4.1).
Zygotes were shipped in groups of 50 per vial containing Tyrodes lactate HEPES (TL
HEPES) and bovine serum albumin (BSA) (see Appendix B). Upon arrival at the EBL
the shipping vials were removed from the portable incubator and stored in a 5% CO2
incubator in humidified air at 39°C until use. Zygotes were then removed from each
individual vial and placed into one Falcon® 35 x 10 mm plastic petri dish containing a TL
HEPES medium (04-616F, Cambrex Bio Science Walkersville, Inc., Walkersville, MD).
Six to eight Falcon® 35 x 10 mm plastic petri dishes were made containing two washes
for each treatment medium (CR1aa medium, fresh and frozen-thawed GX2 commercial
culture medium). All media had been previously equilibrated in a CO2 incubator at 39°C.
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Figure 4.1. Bovine zygotes and 2- to 8-cell embryos received on January 27th from a
commercial supplier (BOMED, Inc., Madison, WI) (10X magnification).
Zygotes were then washed twice in respective treatment medium and 15 zygotes were
randomly selected and placed in each 75 µl culture droplet in a 35 x 10 mm plastic dish.
Prior to placement into in vitro culture the number of 1-cell, 2-cell and 2- to 8-cell
embryos were recorded.
Media Preparation and Use
All chemicals were purchased from Sigma-Aldrich, Inc. (St. Louis, MO) unless
indicated otherwise. The CR1aa laboratory control culture medium has been used for
more than 2 years in our laboratory and was prepared as described previously by
Rosenkrans and First (1994). CR1aa stock solution was prepared by adding 114.7 mM
NaCl (S-5886), 1.6 mM KCl (P-5405), 0.39 mM pyruvic acid (P-4562), 26.2 mM NaHCO3
(S-8875), 2.5 mM L(+)lactic acid (L-4388), 0.5195 mM glycine (G-8790) 0.5051 mM Lalanine (A-7469), and 0.2 ml of 0.5% phenol red per 100 ml of Milli-Q water. The CR1aa
stock solutions were filtered and stored at 4°C for ≤3 months.
The CR1aa control in vitro culture medium for day 1 through day 4 was prepared
on the day of use by combining 9.5 ml CR1aa stock solution, 2% (v/v) of Basal Medium
Eagle (BME) amino acid solution (50X, B-6766), 1% (v/v) of Modified Eagle Medium
(MEM) amino acid solution (10X, 11140-050, Gibco Laboratories, Grand Island, NY), 50
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mg/ml of gentamycin (15750-060, Gibco Laboratories), 1.1 mM L-Glutamine (G-5763)
and 3 mg/ml of BSA (A-7511). Medium was filtered with a 0.2 µm Acrodisc® sterile filter
(PN 4612, Pall Corporation, East Hills, NY). In Falcon® 35 x 10 mm plastic petri dishes,
four 75 µl droplets were made, covered with warmed (39°C) medical grade mineral oil
(330779, Sigma-Aldrich, Inc.) and allowed to equilibrate by placing in an incubator at
39°C for 45 to 60 minutes.
On day 1 of the culture period both fresh and frozen-thawed GX2 medium was
aliquoted into 20 ml and supplemented with 0.3% of BSA (3 mg/ml, A-7511). No
precipitate was observed in the frozen-thawed commercial culture medium. Fresh and
frozen-thawed GX2 culture medium was filtered with a 0.2 µm Acrodisc® sterile filter (PN
4612, Pall Corporation). Four 75 µl droplets were made with fresh and frozen-thawed
medium in two Falcon® 35 x 10 mm plastic petri dishes for each treatment and covered
with warmed medical grade mineral oil (39°C). The dishes were then allowed time to
reach the proper temperature and CO2 equilibration by being placed in an incubator at
39°C for 45 to 60 minutes.
On day 4, the control culture medium (CR1aa) to be used for the next 4 days was
prepared the same as for the day 1 through day 4 culture period but with the addition of
5% FBS. CR1aa culture medium was filtered with a 0.2 µm Acrodisc® sterile filter (PN
4612, Pall Corporation) and placed into two Falcon® 35 x 10 mm plastic petri dishes each
containing four 75 µl droplets that were covered with warmed (39°C) medical grade
mineral oil. Dishes were then allowed time for proper temperature and CO2 equilibration
by being placed in an incubator at 39°C for 45 to 60 minutes.
Also on day 4, the fresh and frozen-thawed GX2 medium to be used for the next 4
days of culture was supplemented with glucose (0.5 mM, as called for by commercial
company protocol). Fresh and frozen-thawed GX2 medium was aliquoted into 20 ml
each and supplemented with 180 mg of glucose, then filtered with a 0.2 µm Acrodisc®
sterile filter (PN 4612, Pall Corporation). Four 75 µl droplets, covered with warmed
(39°C) medical grade mineral oil, were made in two Falcon® 35 x 10 mm plastic petri
dishes for each fresh and frozen-thawed commercial culture medium. The Falcon® 35 x
10 mm plastic petri dishes were then allowed time to reach the proper temperature and
CO2 equilibration by being placed in an incubator at 39°C for 45 to 60 minutes.
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An osmolarity test was run on randomly selected batches of fresh and frozenthawed GX2 commercial culture medium, as well as the CR1aa control. The media
tested was strictly used for this test and not re-used for in vitro culture. The osmolarity of
CR1aa stock, without the addition of bovine serum albumin (BSA) or fetal calf serum
(FCS) was 267 Osm. The average osmolarity of the fresh GX2 commercial culture
medium, without the addition of BSA or glucose was 258 Osm. The average osmolarity
of the frozen-thawed GX2 commercial culture medium, without the addition of BSA or
glucose, was 259 Osm.
Embryo Culture
Prior to placing into culture, zygotes were evaluated for the number of 1-cell, 2cell and 2- to 8-cell embryos and the observations were recorded. Once zygotes were
washed in appropriate culture medium, 15 zygotes were randomly placed in each
appropriate 75 µl droplet contained in Falcon® 35 x 10 mm plastic petri dishes. The
culture dishes were gassed in a humidified cultured chamber with 90% N2, 5% O2 and
5% CO2 for 4 minutes. The humidified chamber containing each treatment was then
placed in an incubator at 39°C to be cultured until day 4 of the experiment.
On day 4 of the culture period, FBS supplemented CR1aa control culture medium
was equilibrated in an incubator at 39°C. Day-4 embryos were evaluated for morphology
and development, and the number of 1-cell, 2- to 8-cell and 8- to 16-cell stages were
recorded. Cleaving embryos were removed from day 1 through day 4 culture droplets
and placed into day 4 through day 8 culture droplets. However, those at the 1-cell stage
were not transferred to new culture medium droplets. The embryos (n=15) were placed
in each 75 µl droplet covered with warmed (39°C) medical grade mineral oil and gassed
with 90% N2, 5% O2 and 5% CO2 for 4 minutes. Humidified chambers containing each
treatment group were then placed in a 39°C incubator and embryos were cultured until
day 8 of the experiment.
Also on day 4 of the culture period, glucose supplemented fresh and frozenthawed GX2 medium was equilibrated in an incubator at 39°C. Day-4 embryos were
evaluated for morphology and development and data were recorded. Development was
grouped by 1-cell, 2- to 8-cell and 8- to 16-cell stages and the remaining 1-cell zygotes
were removed from culture. Cleaving embryos were transferred from day 1 through day
4 culture droplets to corresponding day 4 through day 8 culture droplets. The embryos
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(n=15) were placed in each 75 µl culture droplet covered with warmed (39°C) medical
grade mineral oil and gassed in a humidified culture chamber with 90% N2, 5% O2 and
5% CO2 for 4 minutes. Humidified chambers containing each treatment group were then
placed in a 39°C incubator to be cultured until day 8 of the experiment.
At ~192 hours post-insemination embryos were evaluated for development and
morphological quality. Embryos were evaluated and graded using the RED scores
system as described previously (Ryan et al., 1992). Development was grouped by early
blastocysts, expanded blastocysts, hatching blastocysts and hatched blastocysts.
Statistical Analysis
Variances in embryo development and overall morphology were statistically
analyzed using X2 procedure of SAS (SAS Institute, Inc., Cary, NC). RED scores were
statistically analyzed using the proc mixed procedure of SAS (SAS Institute, Inc.). A
P<0.05 value was considered statistically significant in this study. Descriptive statistics
were analyzed using SigmaStat Statistical Software Version 2.0.

Results
CR1aa Control Culture Medium
The treatment A, laboratory control culture medium, was replicated 12 times from
January 13th to May 5th consisting of the exact same protocol in each replicate. The
percentage of 8- to 16-cell IVF-derived bovine embryos at day 4 of culture is shown in
Figure 4.2a. Following is the percentage of IVF-derived bovine embryos that developed
into blastocysts on day 8 of in vitro culture in CR1aa control medium (Figure 4.2b). A
mean of 54.0% of the embryos in Treatment A developed to the 8- to 16-cell stage on
day 4 of in vitro culture, whereas, the mean blastocyst development on day 8 was 27.0%.
When evaluating 8- to 16-cell stage embryo development on day 4 of in vitro
culture there was a significant difference (P<0.05) found when comparing Replicate 1
(44.0%) with replicates 2 (16.4%), 6 (68.1%), 7 (62.6%), 9 (59.9%) and 12 (64.0%).
When evaluating blastocyst stage development on day 8 of in vitro culture there was no
significant difference found among any of the 12 replicates (Table 4.1). An example of
embryo development in CR1aa control medium is shown in Figure 4.3.
Embryo development was statistically analyzed further by evaluating the variation
of early blastocysts (EB), expanded blastocysts (XB), hatched blastocysts (Hatched) and
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Table 4.1. Percent IVF-derived bovine embryos that developed in weekly
replicates of CR1aa culture medium.

Replicates*

Embryo Stages
Day-4
Day-8
8- to 16-Cells (%)
Blastocysts (%)

1

44.0a

26.0a

2

16.4b

23.6a

3

53.1ab

37.5a

4

55.7ab

34.9a

5

38.6ab

15.7a

6

68.1b

36.3a

7

62.6b

23.7a

8

56.9b

38.8a

9

68.5ab

17.8a

10

59.1ab

26.9a

11

48.5ab

18.2a

12

64.0b

23.0a

52.9

26.9

Mean =

*Total number of 1-cell embryos in the six replicates=1,125.
Values within columns that have different superscpripts are statistically
different at P<0.05.

a,b
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Figure 4.3. Day-8 bovine blastocysts and hatched blastocyst in CR1aa control culture
medium (10X magnification).
hatching blastocysts (Hatching) of each replication. The percentages of day-8 IVFderived bovine embryos that developed to the early blastocyst (EB), expanded blastocyst
(XB) and hatching blastocyst (Hatching) stage in a control CR1aa culture medium are
shown in Figure 4.4. The mean number of embryos that reached the early blastocyst
stage of development was 55.0%, expanded blastocyst stage of development was
39.0%, hatching blastocyst stage of development was 2.0% and hatched blastocyst
stage of development was 4.0%.
When Replicate 1 was evaluated for further development, of the 26.0% total day-8
blastocysts, 46.2% of the IVF-derived embryos cultured in control medium developed
to early blastocysts, 46.2% developed to expanded blastocysts, 0% developed to
hatching blastocysts and 8.0% developed to hatched blastocysts. When Replicate 2 was
evaluated for further development, of the 24.0% total day-8 blastocysts, 69.0% of the
IVF-derived embryos cultured in control medium developed to early blastocysts, 31.0%
developed to expanded blastocysts, 0% developed to hatching blastocysts and 0%
developed to hatched blastocysts. After evaluating Replicate 3 for further development,
of the 37.5% total day-8 blastocysts, 53.0% of the IVF-derived embryos cultured in
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control medium had developed to early blastocysts, 39.0% had developed to expanded
blastocysts, 3.0% had developed to hatching blastocysts and 5.0% had developed to
hatched blastocysts. When Replicate 4 was evaluated for further development, of the
35.0% total day-8 blastocysts, 27.0% of the IVF-derived embryos cultured in control
medium developed to early blastocysts, 59.0% developed to expanded blastocysts, 0%
developed to hatching blastocysts and 14.0% developed to hatched blastocysts. After
evaluating Replicate 5 for further development, of the 16.0% total day-8 blastocysts,
38.0% of the IVF-derived embryos cultured in control medium had developed to early
blastocysts, 46.0% had developed to expanded blastocysts, 8.0% had developed to
hatching blastocysts and 8.0% had developed to hatched blastocysts.
When Replicate 6 was evaluated for further development, of the 36.0% total day-8
blastocysts, 73.0% of the IVF-derived embryos cultured in control medium developed to
early blastocysts, 24.0% developed to expanded blastocysts, 3.0% developed to
hatching blastocysts and 0% developed to hatched blastocysts. When Replicate 7 was
evaluated for further development, of the 24.0% total day-8 blastocysts, 64.0% of the
IVF-derived embryos cultured in control medium developed to early blastocysts, 33.0%
developed to expanded blastocysts, 3.0% developed to hatching blastocysts and 0%
developed to hatched blastocysts. After evaluating Replicate 8 for further development,
of the 39.0% total day-8 blastocysts, 62.2% of the IVF-derived embryos cultured in
control medium had developed to early blastocysts, 31.1% had developed to expanded
blastocysts, 2.2% developed to hatching blastocysts and 4.4% had developed to hatched
blastocysts.
When Replicate 9 was evaluated for further development, of the 18.0% total day-8
blastocysts, 69.0% of the IVF-derived embryos cultured in control medium developed to
early blastocysts, 31.0% developed to expanded blastocysts, 0% developed to hatching
blastocysts and 0% developed to hatched blastocysts. After Replicate 10 was evaluated
for further development, of the 27.0% total day-8 blastocysts, 65.0% of the IVF-derived
embryos cultured in control medium had developed to early blastocysts, 35.0% had
developed to expanded blastocysts, 0% had developed to hatching blastocysts and 0%
had developed to hatched blastocysts. After evaluating Replicate 11 for further
development, of the 19.0% total day-8 blastocysts, 37.0% of the IVF-derived embryos
cultured in control medium had developed to early blastocysts, 53.0% had developed to

80

expanded blastocysts, 5.0% had developed to hatching blastocysts and 5.0% had
developed to hatched blastocysts. When Replicate 12 was evaluated for further
development, of the 23.0% total day-8 blastocysts, 57.0% of the IVF-derived embryos
cultured in control medium developed to early blastocysts, 35.0% developed to
expanded blastocysts, 4.0% developed to hatching blastocysts and 4.0% developed to
hatched blastocysts.
When analyzed, there was a significant difference in early blastocysts
development detected when Replicate 1 was compared with replicates 2, 4, 6, 7, 9 and
10. There was no significant difference in expanded blastocysts development among
any of the 12 replicates. There was also no significant difference in hatching blastocysts
development and hatched blastocysts (development) among replicates, however the
validity of the test is questionable due to the low number of embryos that reached these
developmental stages. An example of hatching and hatched embryo development in
CR1aa control medium is shown in Figure 4.5.
GX2 Commercial Culture Medium
The percent cleavage (day 4) of 2- to 8-cell IVF-derived bovine embryos that
developed during in vitro culture in fresh or frozen-thawed commercial culture medium is
shown in Figure 4.6. The 1-cell zygotes that did not develop were discarded at this point
of the culture period. On day 4 each of the three different storage time periods (Fresh 0
weeks, Fresh 1 week and Fresh 2 weeks) were evaluated for cleavage. When storage
time period for Fresh 0 weeks was evaluated on day 4, cleavage was recorded as 15.7%
1-cell embryos and 23.0% 2- to 8-cell embryos. When storage time period for Fresh 1
week was evaluated on day 4, cleavage was recorded as 10.0% 1-cell embryos and
28.0% 2- to 8-cell embryos. When storage time period for Fresh 2 weeks was evaluated
on day 4, cleavage was recorded as 13.5% 1-cell embryos and 24.0% 2- to 8-cell
embryos. When storage time period for Frozen 0 weeks was evaluated on day 4,
cleavage was recorded as 13.0% 1-cell embryos and 26.0% 2- to 8-cell embryos. When
storage time period for Frozen 1 week was evaluated on day 4, cleavage was recorded
as 10.0% 1-cell embryos and 39.0% 2- to 8-cell embryos. When storage time period for
Frozen 2 weeks was evaluated on day 4, cleavage was recorded as 18.0% 1-cell
embryos and 19.5% 2- to 8-cell embryos.
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A

B

Figure 4.5. Bovine embryos in CR1aa control culture medium. A. Day-8 hatched
blastocyst at 20X magnification. B. A day-9 hatching blastocyst (arrow) at 20X
magnification.
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When evaluating cleavage rates there was a significant difference (P<0.05) in 2to 8-cell development when comparing embryos cultured in fresh control commercial
culture medium (0 weeks) with Fresh 1 week and Frozen 1 week. There was also a
significant difference in cleavage found when comparing stored and frozen treatments
among themselves. A significant difference (P<0.05) was found between storage time
periods for Fresh 1 week compared with Fresh 2 weeks, Frozen 0 weeks and Frozen 2
weeks, as well as, Fresh 2 weeks versus Frozen 1 week, Frozen 0 weeks versus Frozen
1 week and Frozen 1 week versus Frozen 2 weeks.
Development of 8- to 16-Cell Embryos in Culture
The percentages of 8- to 16-cell IVF-derived bovine embryos that developed on
day 4 during in vitro culture in fresh or frozen-thawed commercial culture medium are
shown in Figure 4.7 and Table 4.2. In the commercial culture medium development was
assessed on day 4 at the 8- to 16-cell stage for both Treatment B and Treatment C
(Figure 4.8). Treatment B contained three different storage time periods (Fresh 0 weeks,
Fresh 1 week and Fresh 2 weeks, one or two treatments per replicate) used among the
12 replicates completed. When the first storage time period of Treatment B, Fresh 0
weeks, was evaluated, the percentage of 8- to 16-cell IVF-derived embryos that
developed in fresh commercial culture medium was 57.0%. When storage time period
for Fresh 1 week was evaluated, the percentage of 8- to 16-cell IVF-derived embryos
that developed in fresh commercial culture medium was 52.7%. When the third storage
time period, Fresh 2 weeks, was evaluated, the percentage of 8- to 16-cell IVF-derived
embryos that developed in fresh commercial culture medium was 61.3%.
Treatment C contained three different storage time periods (Frozen 0 weeks,
Frozen 1 week and Frozen 2 weeks) used among the 11 replicates completed. When
the first storage time period of Treatment C, Frozen 0 weeks, was evaluated, the
percentage of 8- to 16-cell IVF-derived embryos that developed in frozen-thawed
commercial culture medium was 58.2%. The next storage treatment time evaluated,
Frozen 1 week, showed the percentage of 8- to 16-cell IVF-derived embryos that
developed in frozen-thawed commercial culture medium was 47.7%. When storage time
period for Frozen 2 weeks was evaluated, the percentage of 8- to 16-cell IVF-derived
embryos that developed in frozen-thawed commercial culture medium was 65.3%.
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Table 4.2. Percentage (±SE) of 8- to 16-cell bovine embryo development in
fresh or frozen-thawed GX2 commercial culture medium.

Medium Storage Time

8- to 16-Cells (%)

Fresh 0 weeks

57.0 ± 6a

Fresh 1 week

52.7 ± 10ab

Fresh 2 weeks

61.3 ± 4ab

Frozen 0 weeks

58.2 ± 3ab

Frozen 1 week

57.7 ± 11ab

Frozen 2 weeks

65.3 ± 5b

a,b

Values with different superscripts are significantly different at P<0.05.
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Figure 4.8. Day-4 bovine embryos in fresh GX2 commercial culture medium (20X
magnification).
There was a significant outlier detected in storage treatment Frozen 1 week. Due
to the fact that this one (outlier) group of 8- to 16-cell embryos were the only group with a
substantial decrease in development a decision was made to remove their
developmental rates from the mean of the Frozen 1 week storage time period. When
this was done there was no significant difference found between Fresh 0 weeks when
compared with Fresh 1 week, Fresh 2 weeks, Frozen 0 weeks and Frozen 1 week.
However, there was a significant difference (P<0.05) found when Fresh 0 weeks was
compared with the storage time period for Frozen 2 week. There was also a significant
difference (P<0.05) detected when comparing the frozen-thawed storage time periods
among themselves. The storage time periods that were found to be significantly different
included Fresh 1 week versus Fresh 2 weeks and Frozen 2 weeks, Fresh 2 weeks
versus Frozen 1 week, Frozen 0 weeks versus Frozen 1 week and Frozen 1 week
versus Frozen 2 weeks.
Blastocyst Development in Culture
The percentage of IVF-derived bovine embryos that developed into blastocysts on
day 8 during in vitro culture in fresh or frozen-thawed commercial culture medium is
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shown in Figure 4.9 and Table 4.3. In the commercial culture medium, development was
assessed on day 8 at the blastocyst stage of development for both Treatment B and
Treatment C (Figure 4.10). Treatment B contained three different storage time periods
(Fresh 0 weeks, Fresh 1 week and Fresh 2 weeks, one or two treatments per replicate)
used among the 12 replicates completed. When the first storage time period of
Treatment B, Fresh 0 weeks, was evaluated, the percentage of IVF-derived blastocysts
that developed in fresh commercial culture medium was 14.2%. When storage time
period for Fresh 1 week was evaluated, the percentage of IVF-derived blastocysts that
developed in fresh commercial culture medium was 18.5%. When the third storage time
period, Fresh 2 weeks, was evaluated, the percentage of IVF-derived blastocysts that
developed in fresh commercial culture medium was 15.4%.
Treatment C contained three different storage time periods (Frozen 0 weeks,
Frozen 1 week and Frozen 2 weeks) used among the 11 replicates completed. When
the first storage time period of Treatment C, Frozen 0 weeks, was evaluated, the
percentage of IVF-derived blastocysts that developed in frozen-thawed commercial
culture medium was 13.9%. The next storage treatment time evaluated, Frozen 1 week,
showed the percentage of IVF-derived blastocysts that developed in frozen-thawed
commercial culture medium was 10.0%. When storage time period for Frozen 2 weeks
was evaluated, the percentage of IVF-derived blastocysts that developed in frozenthawed commercial culture medium was 17.7%.
There was no significant difference found when Fresh 0 weeks was compared
with any of the other storage time periods. There was a significant difference (P<0.05) in
blastocyst development found when comparing Fresh 1 week versus Frozen 1 week,
Fresh 2 weeks versus Frozen 1 week and Frozen 1 week versus Frozen 2 weeks.
Embryo development was statistically analyzed further by evaluating the variation
of early blastocysts, expanded blastocysts, hatched blastocysts and hatching blastocysts
of each treatment group (4.11). The percentages of day-8 IVF-derived bovine
blastocysts that developed to the early blastocyst and expanded blastocyst stage in fresh
or frozen-thawed commercial culture medium are shown in Figure 4.12. When Fresh 0
weeks was evaluated for further development, of the 14.2% total blastocysts, 72.0% of
IVF-derived embryos cultured in fresh commercial culture medium developed to early
blastocysts, 28.0% developed to expanded blastocysts, 0% developed to hatching
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Table 4.3. Percentage (±SE) of IVF-derived bovine blastocysts that developed in
fresh or frozen-thawed GX2 commercial culture medium.

Medium Storage Time

Blastocysts (%)

Fresh 0 weeks

14.2 ± 3a

Fresh 1 week

18.5 ± 4a

Fresh 2 weeks

15.4 ± 3a

Frozen 0 weeks

13.9 ± 2a

Frozen 1 week

10.0 ± 4a

Frozen 2 weeks

17.7 ± 2a

a,b

Values with different superscripts are significantly different at P<0.05.
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Figure 4.10. Day-8 expanded blastocyst in fresh GX2 commercial culture medium (20X
magnification).

Figure 4.11. Day-8 hatching blastocyst in fresh GX2 commercial culture medium (20X
magnification).
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blastocysts and 0% developed to hatched blastocysts. When Fresh 1 week was
evaluated for further development, of the 18.5% total blastocysts, 62.0% of IVF-derived
embryos cultured in fresh commercial culture medium developed to early blastocysts,
37.0% developed to expanded blastocysts, 1.0% developed to hatching blastocysts and
0% developed to hatched blastocysts. When Fresh 2 weeks was evaluated for further
development, of the 15.4% total blastocysts, 74.0% of IVF-derived embryos cultured in
fresh commercial culture medium developed to early blastocysts, 23.0% developed to
expanded blastocysts, 3.0% developed to hatching blastocysts and 0% developed to
hatched blastocysts.
When Frozen 0 weeks was evaluated for further development, of the 13.9% total
blastocysts, 70.0% of IVF-derived embryos cultured in frozen-thawed commercial culture
medium developed to early blastocysts, 26.0% developed to expanded blastocysts, 2.0%
developed to hatching blastocysts and 2.0% developed to hatched blastocysts. When
Frozen 1 week was evaluated for further development, of the 10.0% total blastocysts,
62.0% of IVF-derived embryos cultured in frozen-thawed commercial culture medium
developed to early blastocysts, 36.0% developed to expanded blastocysts, 2.0%
developed to hatching blastocysts and 0% developed to hatched blastocysts. When
Frozen 2 weeks was evaluated for further development, of the 17.7% total blastocysts,
64.0% of IVF-derived embryos cultured in frozen-thawed commercial culture medium
developed to early blastocysts, 32.0% developed to expanded blastocysts, 4.0%
developed to hatching blastocysts and 0% developed to hatched blastocysts. No
significant difference was detected when comparing early blastocyst or expanded
blastocyst development between storage time period Fresh 0 weeks and the remaining
storage time periods (Fresh 1 week, Fresh 2 weeks, Frozen 0 weeks, Frozen 1 week and
Frozen 2 weeks).
The mean RED scores for IVF-derived bovine embryos recorded on day 8
following in vitro culture in fresh or frozen-thawed commercial culture medium is shown
in Figure 4.13 and Table 4.4. In the commercial culture medium, morphology on day 8
was assessed as well as development for all storage time periods in both the fresh and
frozen-thawed culture medium. A RED score was assigned to each embryo based on
morphology and stage of development (Figure 4.14). When storage time period for
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Table 4.4. Mean RED scores (±SEM) recorded on day 8 following bovine embryo culture in fresh
or frozen-thawed GX2 commercial culture medium.

Embryos*
Medium Storage Time

Early Blastocysts

Expanded Blastocysts

Fresh 0 weeks

1.86 ±0.02a

2.98 ±0.02a

Fresh 1 week

1.86 ±0.07a

2.91 ±0.04a

Fresh 2 weeks

1.81 ±0.04a

2.94 ±0.04a

Frozen 0 weeks

1.86 ±0.02a

2.96 ±0.04a

Frozen 1 week

1.88 ±0.01a

2.93 ±0.07a

Frozen 2 weeks

1.84 ±0.03a

2.93 ±0.07a

a,b

Mean values within columns that have different superscripts are significantly differerent at P<0.05.
*Embryos were evaluated on day 8 of culture.
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A

B

Figure 4.14. Day-8 bovine embryos in frozen-thawed GX2 commercial culture medium.
A. Day-8 blastocysts at 20X magnification. B. Day-8 blastocysts and expanded
blastocyst at 20X magnification.
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Fresh 0 weeks was evaluated, the mean RED score for the early blastocysts of IVFderived embryos that developed in fresh commercial culture medium was 1.86% and the
mean RED score for the to expanded blastocysts was 2.98%. When the next storage
time period, Fresh 1 week, was evaluated, the mean RED score for the early blastocysts
of IVF-derived bovine embryos that developed in fresh commercial culture medium was
1.86% and the mean RED score for the expanded blastocysts was 2.91%. When
storage time period for Fresh 2 weeks was evaluated, the mean RED score for the early
blastocysts of IVF-derived embryos that developed in fresh commercial culture medium
was 1.81% and the mean RED score for the expanded blastocysts was 2.94%.
When storage time period for Frozen 0 weeks was evaluated, the mean RED
score for the early blastocysts of IVF-derived embryos that developed in frozen-thawed
commercial culture medium was 1.86% and the mean RED score for the expanded
blastocysts was 2.96%. When storage time period for Frozen 1 week was evaluated, the
mean RED score for the early blastocysts of IVF-derived embryos that developed in
frozen-thawed commercial culture medium was 1.88% and the mean RED score for the
expanded blastocysts was 2.93%. When storage time period for Frozen 2 weeks was
evaluated, the mean RED score for the early blastocysts of IVF-derived embryos that
developed in frozen-thawed commercial culture medium was 1.84% and the mean RED
score for the expanded blastocysts was 2.93%. There was no significant difference
among early blastocysts or among expanded blastocysts analyzed between the control
storage time period Fresh 0 weeks and any of the other fresh or frozen-thawed storage
time periods (Fresh 1 week, Fresh 2 weeks, Frozen 0 weeks, Frozen 1 week and Frozen
2 weeks).

Discussion
As in vitro fertilization and embryo transfer (IVF/ET) becomes more accepted by
infertile patients, one of the most critical aspects to consider is how the gametes and
embryos are to be maintained in the laboratory until they are transferred to the patient.
Therefore, it very important that the best culture media available is selected for in vitro
incubation. De Silva (1993) reported in a human IVF program, preparation and quality
control of the embryo culture medium can be very time-consuming and expensive. Many
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researchers believe that medium stored for up to 2 weeks is the limit, after that the
medium is no longer suitable for embryo culture (Purdy, 1982; Quinn et al., 1984; Gerrity
et al., 1992; McLendon, 1992).
There have been a few researchers who have shown that embryo culture medium
can be stored or frozen for various amounts of time much longer than 2 weeks (Naz et
al., 1986; Bernart et al., 1990; De Silva, 1993; Bell et al., 1995). This extended storage
time would create many advantages for analyzing and selecting the best culture medium
for human embryos. More assays could be run on the same batch of medium exposing
more gametes and embryos to the same batch of medium thus, being more time efficient
and inexpensive using the same medium for a longer period of time. Freezing culture
medium would offer more opportunity for these advantages to be utilized.
However, there are many unknowns and very little research done in freezing
embryo culture medium. It has been proposed that freezing the commercial culture
medium at -80°C would create less of a biochemical breakdown of the components,
therefore, allowing for an improved developmental rate for IVF embryos cultured in
frozen-thawed medium.
In this experiment, a control CR1aa IVF culture medium was used to confirm
laboratory techniques and to evaluate embryo development obtained with a protocol that
had been previously proven in our laboratory. When cold storing the stock CR1aa
control medium at 4°C for 3 months, we have observed similar or increased morula and
blastocyst development rates when compared with the results reported with IVF-derived
bovine embryos by Rosenkrans and First (1994).
The replicates were performed simultaneously with the fresh and frozen-thawed
IVF procedures of our study to ensure technique and quality control for our laboratory. A
significant difference was noted in 8- to 16-cell embryo development among a few
replicates, however, when evaluating blastocyst development no significant difference
among replicates was detected in CR1aa control culture medium. When development
was further analyzed to the early blastocyst and expanded blastocyst stages a significant
difference was found among early blastocyst development rates but not among
expanded blastocyst development rates.
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Cleavage was evaluated and recorded at two culture intervals in the present
experiment for the commercial culture medium; the number of 2- to 8-cell embryos on
day 4 of culture and the number of 8- to 16-cells on day 4 of culture. When evaluating
the control storage time period Fresh 0 weeks versus frozen-thawed commercial culture
medium there was a significant increase in cleavage found in 2- to 8-cell embryos
cultured in Fresh 1 week medium and Frozen 1 week medium.
In this experiment, when evaluating 8- to 16-cell development we found no
significant decrease in development when comparing the fresh control (0 weeks)
commercial culture medium to any of the stored or frozen (-80°C) commercial culture
medium treatments (Fresh 1 week, Fresh 2 weeks, Frozen 0 weeks, Frozen 1 week and
Frozen 2 weeks). We did remove a significant outlier in the Frozen 1 week storage time
period. An anomaly in culture is assumed to have caused this significant decrease in 8to 16-cell development for this one replicate. Around the time period for this replicate the
laboratory was undergoing construction and the floors were being waxed (a strong odor
was recorded), however, why this treatment group would be the only group of that
replicate that suffered significantly from these adverse effects is unknown. In storage
period time Fresh 2 weeks and Frozen 0 weeks 8- to 16-cell embryos development is
actually slightly higher than that of the control Fresh 0 weeks. Although there was a
pattern for development to be greater for the 2 week stored medium and the 0 weeks
frozen-thawed medium than the fresh control medium, there was no significant difference
between the storage times and the control. However, there was a significant increase in
development when comparing 8- to 16-cell stage embryos cultured in fresh medium (0
weeks) as opposed to those embryos cultured in medium frozen at -80°C for 2 weeks.
There is no explanation for the increased development as frozen storage time increased.
There was no significant difference observed in blastocyst development when
comparing the control storage time period Fresh 0 weeks versus any of the other fresh
storage time periods or frozen storage time periods. In a similar study, Bernart et al.
(1990) obtained results, using a different frozen-thawed culture medium, in murine and
human embryo culture that are in agreement with those in our experiment. When
Bernart et al. (1990) evaluated mouse embryos in Ham’s F-10 medium frozen at -20°C
for up to 6 months there was no significant difference in embryo development. They then
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evaluated the development of human embryos and found no significant difference in the
rates of expanded and hatched blastocysts cultured in fresh Ham’s F-10 medium or in
medium stored frozen for various intervals from 2 weeks to 3 months. As noted by
Bernart et al. (1990) with human embryo culture, in our present study we saw a pattern
of development to be greater for embryos cultured in medium frozen for 2 weeks
compared with the control Fresh 0 week embryos. There was no significant difference
noted in development when comparing different storage time periods of the frozen
medium among each other.
When development was evaluated further to the early blastocyst and expanded
blastocyst stages there was no difference in either developmental stage when compared
among treatment groups. Bernart et al. (1990) found similar result when comparing
development among murine embryo subgroups cultured in fresh or frozen medium for
various intervals between 2 weeks and 6 months, there was no significant difference in
the rates of expanded and hatched blastocyst stage embryos.
When examining mean RED scores of early blastocysts in the present study,
there was no significant difference in the grades of IVF-derived bovine embryos among
the control fresh storage time period versus any of the other fresh or frozen-thawed
storage period times. There was no significant difference in mean RED scores among
expanded blastocysts when evaluating the control fresh storage time period versus any
of the other fresh or frozen-thawed storage period times. In contrast, Ryan et al. (1992)
noted a significant effect of time in co-culture and treatment on resulting RED scores
when analyzing heat stressed bovine embryos.
The results of this study indicate that freezing human commercial culture medium
at -80°C (for 1 month), then storing for up to 2 weeks resulted in no significant decrease
in 8- to 16-cell development or blastocyst development. The results of this study could
be helpful to human fertility clinics in the future use of frozen-thawed culture media and
the subsequent effects it may or may not have on embryo development at the 8- to 16cell stage and blastocyst stage in vitro. Edwards et al. (1980) and Steptoe et al. (1980)
first described the details of transferring cleavage stage embryos into the synchronized
uterus of the human female. Since these early reports, it has been the norm of human
fertility clinics to transfer embryos at the 8- to 16-cell stage. However, recent advances
in culture media preparations have allowed cleavage stage human embryos to be
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cultured out to the blastocyst stage (Barnes et al., 1995; Gardner et al., 1998; Jones and
Trounson, 1999; Cruz et al., 1999; Behr et al., 1999; Schoolcraft et al., 1999; Milki et al.,
2000; Gardner et al., 2000; Alper et al., 2001;). There are a number of advantages to
culturing human embryos out to the blastocyst stage such as; selection for a higher
quality embryo, reduced number of embryos transferred and decreased incidence of
multiple gestation. Although there are advantages, as of today there are more research
studies reported on transferring human embryos at the 8- to 16-cell stage. Clinicians are
advised to evaluate data carefully before offering blastocyst transfer routinely, while we
await an improved understanding of embryo development (Alper et al., 2001).
When analyzing the rest of the results development is not different in blastocyst
numbers or RED score values indicating that overall embryos were not impaired in the
commercial culture medium frozen for 1 month at -80°C and stored for up to 2 weeks.
We can assume that GX2 commercial culture medium can be frozen at -80°C, stored for
up to 2 weeks and used without any deleterious effects on day 8 bovine blastocyst
development and morphology.
The findings of this study are promising to the future of culturing human embryos
in frozen-thawed (-80°C) medium. Barnes and Eyestone (1990) indicated that although
the media requirements are slightly different, similar mechanisms are observed in bovine
and human embryo development. Brackett et al. (1982) stated that the further
development and application of in vitro fertilization in cattle should provide information
helpful in better management of problems related to human fertility and in efforts to
develop procedures for human fertilization in vitro. There are a number of similarities in
the human and bovine species a few being; similar gestation periods, both bearing a
single offspring, as well as, the desirability for transfer of in vitro fertilized embryos into
surrogates other than the ovum donor. Continued research of the bovine model is
supported by these similarities between the human and bovine species and the findings
of this study.
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CHAPTER V
SUMMARY AND CONCLUSIONS
The primary objective of this study was to examine the potential of using frozenthawed human commercial culture medium for successful IVF procedures. Little
research has been reported on freezing human culture media and subsequent embryo
post thaw development. New information on frozen-thawed culture media would allow
fertility clinics to explore more efficient methods for IVF procedures by setting up
improved quality control culture measures.
In this study, bovine embryos were used because it is illegal in most states to
perform research on human embryos. The first experiment evaluated the in vitro
development of bovine embryos in human commercial culture medium frozen and stored
at -20°C. The medium (GX2) was frozen and stored for a period of 3 days to 10 weeks
(Frozen 3 days, Frozen 2 weeks, Frozen 4 weeks, Frozen 6 weeks, Frozen 8 weeks and
Frozen 10 weeks). Embryos were analyzed for development and morphology on day 4
and day 8 of in vitro culture. There was a significant decrease in development of the 8to 16-cell stage embryos cultured in frozen medium for 8 to 10 weeks at -20°C. There
was, however, no decrease in blastocyst development or embryo quality for the embryos
cultured in medium frozen for up to 10 weeks at 20°C. There was no decrease in
number of cell per embryo when blastocysts were cultured in medium frozen at -20°C for
up to 10 weeks, when compared with the fresh control (Fresh 0 weeks).
In the second experiment, bovine embryos were used to evaluate human
commercial culture medium frozen at -80°C (for 1 month). Again, there were a number
of different fresh and frozen storage time periods utilized to culture these bovine embryos
(Fresh 0 weeks, Fresh 1 week, Fresh 2 weeks, Frozen 0 weeks, Frozen 1 week and
Frozen 2 weeks). The time periods in this experiment consisted of commercial culture
medium being stored at 4°C from 0 to 2 weeks and frozen at -80°C for 1 month then
stored at 4°C from 0 to 2 weeks. Embryos were analyzed for development and
morphology on day 4 and day 8 of in vitro culture. The results indicate that 8- to 16-cell
stage embryos cultured in medium frozen at -80°C and stored for up to 2 weeks resulted
in no decreased development. Embryos reaching the 8-to 16-cell stage in frozen
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medium (-80°C) and stored for 2 weeks actually showed a significant increase in
development. No explanation can be made for this increased development in medium
that was frozen/stored for 2 weeks over that of the control medium (Fresh 0 weeks).
Overall, it was concluded that bovine embryos can be cultured in medium frozen at -80°C
resulting in no decreased development or quality at the 8- to 16-cell stage or the
blastocyst stage.
It was concluded that it is possible to freeze human commercial culture medium at
either -20°C or -80°C without decreasing blastocyst development and overall embryo
quality. To our knowledge this is the first report to evaluate the use of bovine embryos
developed to the blastocyst stage (day 8) in frozen-thawed human commercial culture
medium. The data and protocols gained herein can be used as guidelines to generate
the next experiment or adapted as a model for fertility clinics trying to freeze/store
embryo culture media.
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APPENDIX A: OOCYTE PROTOCOL AND MEDIA
Oocyte Aspiration Protocol (BOMED, Inc., Madison, WI)

1. Aspirate using a vacuum pump set a 5 psi into 50 ml conical tubes.
2. A stopper that fits the tube has two 18 g needles stuck through it, and a bent
glass tube with the cut off end of a 1 ml syringe fitted to it so it can hold an 18 g
needle.
3. Tygon tubing runs from the vacuum pump and also has a cut off 1 ml syringe
attached to fit in one of the 18 g needles that runs through the stopper.
4. Follicles 2 mm or greater are aspirated until about 8 mm is obtained and the tube
is filled.
5. Let sit 15 minutes and take out the settled pellet with a Pasteur.
6. Dilute with wash and search for oocytes.
7. Wash the pellet through a 70 µm tissue filter.
Oocyte Wash Medium (BOMED, Inc., Madison, WI)

Component
TL-HEPES
BSA-Fraction-V

Information

Amount

AB Technologies

-

-

3 mg/ml

Gentamycin

Sigma

50 µg/ml

Na pyruvate

Sigma

0.22 mM

Oocyte Maturation Medium (BOMED, Inc., Madison, WI)

Component

Information

Amount

TCM199 with Earl’s salts

Cambrex

-

10% FCS

Cambrex

-

Bovine LH

Sioux Biochemicals

3 µg/ml

Bovine FSH

Sioux Biochemicals

3 µg/ml

Gentamycin

Sigma

25 µg/ml

Na pyruvate

Sigma

0.22 mM

Filter with Millipore filters and put into vials, equilibrate in incubator for several hours.
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APPENDIX B: FERTILIZATION MEDIUM, PROTOCOL AND CR1aa
STOCK MEDIUM
Oocyte Fertilization Medium (BOMED, Inc., Madison, WI)

Supplementation of IVF (Specialty Media Inc., Lavallette, NJ)
Component
Fatty acid-free BSA
Gentamycin stock (50 mg/ml)
Na pyruvate stock

Information

Amount

-

6 mg/ml

Sigma or Cambrex
-

0.5 µg/ml
10 µg/ml

Na pyruvate stock made fresh daily (22 mg/5 ml of TL- HEPES). Millipore with 0.22 µm
filter and allow to equilibrate 3 to 4 hours in incubator.
Fertilization Protocol (BOMED, Inc., Madison, WI)

1. Gas mix is 5% CO2 in air.
2. Sperm/oocyte culture is done 18 to 20 h at 39°C in high humidity.
3. PHE and heparin are used as capacitation agents.
4. Sperm is prepared for fertilization through 45/90% Percoll gradient.
5. Sperm are then prepped in TL-HEPES wash.
6. Sperm are used at 1 x 106 per ml final concentration.
7. Oocyte complexes and sperm are co-incubated for 16 to 20 hours.
8. Oocyte complexes are then vortexed and washed in TL-HEPES wash and placed
into SOFaa for culture or TL-HEPES with BSA for shipping.
CR1aa Stock Medium (100 ml)

Component

Information

Amount

NaCl

S-5886 (Sigma)

0.6703 g

KCl

S-5405 (Sigma)

0.0231 g

NaHCO3

S-8875 (Sigma)

0.2201 g

Pyruvic Acid

P-2256 or P-4562 (Sigma)

0.0044 g

L(+)Lactic Acid

L-4388 (Sigma)

0.0546 g

Glycine

G-8790 (Sigma)

0.0039 g

L-Alanine

A-7469 (Sigma)

0.0045 g
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APPENDIX C: CR1aa CULTURE MEDIUM
Milli Q water (DD water)
Phenol Red 0.5%

P-0290

100 ml
0.2 ml (200 µl)

Make in a 100 ml bottle and then filter into two 50 ml tubes.
Place para film around the bottle and store in refrigerator for up to 3 months.
CR1aa Embryo Culture Medium for Day 1 Through Day 4 of Culture (10 ml)

Component
CR1aa Stock

Information

Amount

-

9.5 ml

BME aa solution (50X)

B-6766 (Sigma)

200 µl

MEM aa solution (10X)

11140-050 (Gibco)

100 µl

Gentamycin (50 mg/ml)

15750-060 (Gibco)

10 µl

L-Glutamine

G-5763 (Sigma)

BSA

A-7511 Sigma

Insulin

0.00146 g
0.03 g

-

10 µl

Make in 15 ml conical tube, filter and place in incubator for 30 to 45 minutes.
CR1aa Embryo Culture Medium for Day 4 Through Day 8 of Culture (10 ml)

Component
CR1aa Stock

Information

Amount

-

9.5 ml

BME aa solution (50X)

B-6766 (Sigma)

200 µl

MEM aa solution (100X)

11140-050 (Gibco)

100 µl

FBS (Fetal bovine serum)

-

500 µl

Gentamycin (50 mg/ml)

15750-060 (Gibco)

L-Glutamine

G-5763 (Sigma)

BSA

A-7511 Sigma

0.03 g

-

10 µl

Insulin

Make in 15 ml conical tube, filter and place in incubator for 30 to 45 minutes.
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10 µl
0.00146 g

APPENDIX D: EXPERIMENT I WEEKLY REPLICATES
Appendix D. Six weekly replicates performed from April 30th to July 9th containing
a group of bovine zygotes in vitro cultured in each treatment media.
Replicate Number
1
1
1
1
1
2
2
2
2
2
3
3
3
3
3
4
4
4
4
4
5
5
5
5
5
6
6
6
6
6

Replicate Date

Media Used

4/30/2004
4/30/2004
4/30/2004
4/30/2004
4/30/2004
5/14/2004
5/14/2004
5/14/2004
5/14/2004
5/14/2004
5/28/2004
5/28/2004
5/28/2004
5/28/2004
5/28/2004
6/11/2004
6/11/2004
6/11/2004
6/11/2004
6/11/2004
6/25/2004
6/25/2004
6/25/2004
6/25/2004
6/25/2004
7/9/2004
7/9/2004
7/9/2004
7/9/2004
7/9/2004

CR1aa
Fresh 0 weeks
Frozen 10 weeks
Frozen 2 weeks
Frozen 3 days
CR1aa
Fresh 0 weeks
Frozen 4 weeks
Frozen 2 weeks
Frozen 3 days
CR1aa
Fresh 0 weeks
Frozen 6 weeks
Frozen 4 weeks
Frozen 2 weeks
CR1aa
Fresh 0 weeks
Frozen 8 weeks
Frozen 6 weeks
Frozen 4 weeks
CR1aa
Fresh 0 weeks
Frozen 10 weeks
Frozen 8 weeks
Frozen 6 weeks
CR1aa
Fresh 0 weeks
Frozen 10 weeks
Frozen 8 weeks
Frozen 3 days
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Number of zygotes
30
30
130
130
30
30
30
130
130
30
30
30
96
96
96
30
30
96
96
96
30
30
96
96
96
30
30
130
130
30

APPENDIX E: EXPERIMENT II WEEKLY REPLICATES
Appendix E. Twelve weekly replicates performed from January 13th to May 5th containing
a group of bovine zygotes in vitro cultured in each treatment media.
Replicate Number
1
1
1
1
2
2
2
3
3
3
4
4
4
4
5
5
5
6
6
6
7
7
7
7
8
8
8
9
9
9
10
10
10
10
11
11
11
12
12
12
12

Replicate Date
1/13/2005
1/13/2005
1/13/2005
1/13/2005
1/20/2005
1/20/2005
1/20/2005
1/27/2005
1/27/2005
1/27/2005
2/10/2005
2/10/2005
2/10/2005
2/10/2005
2/17/2005
2/17/2005
2/17/2005
2/24/2005
2/24/2005
2/24/2005
3/10/2005
3/10/2005
3/10/2005
3/10/2005
3/17/2005
3/17/2005
3/17/2005
3/24/2005
3/24/2005
3/24/2005
4/7/2005
4/7/2005
4/7/2005
4/7/2005
4/14/2005
4/14/2005
4/14/2005
5/5/2005
5/5/2005
5/5/2005
5/5/2005

Media Used
CR1aa
Fresh 0 weeks
Fresh 2 weeks
Frozen 0 weeks
CR1aa
Fresh 1 week
Frozen 1 week
CR1aa
Fresh 2 weeks
Frozen 2 weeks
CR1aa
Fresh 0 weeks
Fresh 2 weeks
Frozen 0 weeks
CR1aa
Fresh 1 week
Frozen 1 week
CR1aa
Fresh 2 weeks
Frozen 2 weeks
CR1aa
Fresh 0 weeks
Fresh 2 weeks
Frozen 0 weeks
CR1aa
Fresh 1 week
Frozen 0 weeks
CR1aa
Fresh 2 weeks
Frozen 2 weeks
CR1aa
Fresh 0 weeks
Fresh 2 weeks
Frozen 0 weeks
CR1aa
Fresh 1 week
Frozen 1 week
CR1aa
Fresh 0 weeks
Fresh 2 weeks
Frozen 0 weeks

126

Number of zygotes
50
100
100
100
55
100
100
96
100
100
106
100
100
100
83
100
100
91
100
100
139
100
100
102
116
100
100
73
100
100
115
100
100
100
101
100
100
100
100
100
100
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